SlideShare a Scribd company logo
Al-Zaytoonah University of Jordan
Faculty of Pharmacy
Medicinal Chemistry 3
Course #: 0201414
3 Credit Hours
Part 1
Rima Hajjo, MS, PhD
rima.hajjo@zuj.edu.jo
Course Outline
1) Antibacterial/Antimicrobial Agents
2) Antibiotics
3) Antimycobacterial agents
4) Antifungal agents
5) Anti-parasites
6) Antiviral agents
7) Anticancer agents
Al-Zaytoonah University of Jordan
Faculty of Pharmacy
MedChem 3
Course #:
3 Credit Hours
Antimicrobial/Antibacterial Agents
Ø Sulfonamides
Ø Quinolones
Ø Nitrofurans
Ø Methenamine
Ø Fosmycin
Ø Metronidazole
Foye’s Medicinal Chemistry Book
Book
Introduction: Mechanisms of Antibacterial Agents
Madigan and Martinko, 2006
Fostomycin
(1) SULFONAMIDES
ØSynthetic Antibacterial Agents
ØUsed Mainly for Urinary Tract Infections (UTIs)
ØGeneral Considerations:
• First, Sulfonamides came into use in the mid 1930’s
• Then Penicillins in the 40’s
• Combination therapies in the 1970’s (Co-trimoxazole)
• FLuoroquinolones in the 1990’s
ØTherapeutic Indications:
• Lower UTI’s – urethritis, cystitis, prostatitis
• Upper UTI’s – Pyelonephritis
The Discovery of Sulfonamides Antibacterial Agents
Prontosil rubrum and patented as Prontosil, is
an azo dye, introduced in 1935 by Gerhard
Domagk, Bayer, Germany.
Inactive in vitro!
Active in vivo.
Natural Bacterial Metabolite
Antimetabolite
PABA
p-aminobenzenesulfonic acid amide
Azo bond confers prodrug qualities
“Azo compound”
The first drug to successfully treat bacterial infections and the first of many sulfa drugs—
forerunners of antibiotics. This achievement earned its creator a Nobel Prize.
reductive
cleavage of the
azo bond
Mechanism of Action: Sulfonmaides Inhibit Microbial
Biosynthetic Pathway of Tetrahydrofolic Acid Synthesis
Glutamic acid
6-hydroxymethyl-7,8-dihydropterin-pyrophosphate
The basis of selective toxicity to bacteria is clear! Bacteria need to synthesize THFA in vivo,
while humans rely on food and supplements for folic acid and don’t synthesize it in vivo.
Sulfonamides are
bacteriostatic
‘THFA’
THFA is required
for DNA synthesis
Structure Activity Relationships (SAR) of
Sulfonamides
SAR:
1. N4 must be unsubstitued or capable of regeneration of NH2
2. No substitution on the aromatic ring
3. Acidic proton on N1
S
H2N
O
O
N
H
H
C
H2N
O
O
H
pKa = 6.5
pKa = 10.4
Acidic
Ar = pKa
N
O
H3C CH3
5.0
MIC
2.15
H 10.4 128.0
O
N
CH3
6.0 0.8
N
N
6.52 0.9
N
N
S
5.5 ---
CH3
S
H2N
O
O
N
H
Ar
4. Exchange SO2NHR by CONHR reduces the activity (because
of decreased acidity of N1 proton)
5. The amine and sulphonamide groups have to be para to each other
PABA
Sulfanilamide
N4
N1
Thiadiazole
Pyrimidine
Isoxazole
Isoxazole
Pharmacokinetics of Sulfonamides
S
H2N
O
O
N
H
Ar
S
NH
O
O
N
H
Ar
C
O
H3C
N4 acetylation (aniline nitrogen)
“Inactive”
1) Metabolism
S
H2N
O
O
N
Ar
Salt
2) Salt formation
“Acidic proton allows salt formation”
Acidic proton
Sodium Salts are very alkaline because Na+ is quite alkaline (more irritation) causing crystalurea
N
OH
OH
H
H
Diethanolamine is close to neutral and its sulfonamide salts are nearly neutral (i.e., less irritation)
Site of acetylation
“less painful/less irritation for eyes”
Diethanolamine
Irritation
Two problems: 1) Inactivated by metabolism and 2) low water solubility
Pharmacokinetics
1) Most sulfonamides are well absorbed orally and they
are widely distributed including to the CNS.
2) The concentrations in the kidney are the highest. So
they are suitable for treating urinary tract infections.
3) Lower solubility in the urine, most sulfonamides and
their metabolites easily cause crystalluria, bloody
urine, and kidney damage.
According to administration route and the degree of absorption in
intestinal tract, can be divided into:
①Oral, absorbable: well absorbed in intestinal tract and mainly
used to treat general infections. On the basis of their half-lives,
also be classified as short-, medium-, or long-acting ones such
as sulfisoxazole, sulfamethoxazole and sulfadoxine;
②Oral, nonabsorbable: poorly absorbed in intestinal tract and
mainly used to treat intestinal tract infections; such as
sulfasalazine.
③Topical: such as SD-Ag and sulfamylone.
Clinical Uses and “Classification of Sulfonamides”
Orally Absorbable
S
O
O H
N
O
N
H2N
S
O
O
NH
H2N
N
N
Sulfamethoxazole Sulfadiazine
Sulfisoxazole Sulfadoxine
Sulfamethizole
Mafenide/Sulfamylone (Burns)
Topical
S
O
O
NH
H2N
O
Sulfacetamide (Eye drops)
Silver sulfadiazine (Wounds, Burns)
Sulfasalazine (intestinal infections)
Orally Nonabsorbable
mafenide acetate
Resistance to Sulfonamides
ØUsually occurs by increasing the PABA concentration or a
change in the enzyme structure to better distinguish between
PABA and the drug.
ØSome bacteria are intrinsically resistant since they can uptake
Folic acid from their surroundings.
ØThe use of sulfamethoxazole and other sulfonamides has been
limited by the increasing incidence of resistant organisms. Their
main use has been in the treatment of acute, uncomplicated
urinary-tract infections, particularly those caused by Escherichia
coli.
Combination Therapy for UTIs: Sulfonamide +
Trimethoprim
N
N
N
N
O
H2N
H
H
O P
O
O
OH
P
O
OH
OH H2N
CO2H
PABA
+ N
N N
N
O
H2N
N
CO2H
H
H
H
Dihydropteroic Acid
Glutamic acid
N
N N
N
O
H2N
N
C N
CO2H
CO2H
Dihydrofolic Acid
H
H
H
o
H
Dihydrofolate
reductase
N
N N
N
O
H2N
N
C N
H
CO2H
CO2H
Tetrahydrofolic Acid
H
H
H
H
O
S
H2N
O
O
N
H
H
Dihydropteroate diphosphate
Trimethoprim
Dihydropteroate
Synthase
Sulfonamide
Trimethoprim
Site of action of
trimethoprim
Antimetabolite
Al-Zaytoonah University of Jordan
Faculty of Pharmacy
MedChem 3
3 Credit Hours
Rima Hajjo, MS, PhD
rima.hajjo@zuj.edu.jo
(2) Quinolone/Fluoroquinolone Antibacterial Agents
Quinolones: Background
Ø Broad spectrum antibacterial.
Ø The first discovered quinolone antibacterial for clinical use was Nalidixic acid (not in
clinical use anymore because safer quinolones were discovered).
Ø Now, nearly all quinolone drugs in clinical use are fluoroquinolones.
Ø We developed/used as antibacterial agents in the 60s.
Nalidixic acid
Ø Due to increased concerns about toxicities
and side effects, the FDA issued black box
warnings in 2008, 2016, 2018.
Example on black box warning for other drugs
General Structure and Pharmacophore
1
2
3
4
5
6
7
8
Spectrum of activity
Atom number 8 used to be N, then changed
to C to reduce side effects. Most quinolone
drugs in clinical use have C at position 8.
Mechanism of action of Quinolones
ØQuinolones inhibit bacterial
topoisomerase enzymes, resulting in
inhibition of replication and transcription.
ØInhibition of DNA gyrase in G- (also called
topoisomerase II in G-) and
topoisomerase IV in G+, which are key
bacterial enzymes that dictate the
conformation of DNA à that’s why the
quinolones are rapidly bactericidal.
ØNalidixic acid was the first quinolone introduced to clinic in 1962 to fight against
Gram negative urinary tract infections (UTIs) à it is considered a first-
generation quinolone based on its spectrum of activity and pharmacokinetic
properties. It is discontinued.
ØFirst-generation agents are limited to uncomplicated urinary tract infections.
And they have problems with toxicity, antibacterial spectrum, and metabolism.
1
2
3
4
First Generation Quinolones
Second Generation Quinolones
Broader spectrum against Gram Negative
Longer half life
Less protein binding when X = CH
Third Generation Quinolones
The third-generation quinolones include levofloxacin, gatifloxacin, and gemifloxacin.
It is 4th generation in some references
Fourth Generation Quinolones
The first chlorinated
fluoroquinolone developed.
Trovafloxacin
Removed from clinical use in 1999
Hepatotoxic
Summary
Generation Agents
Antimicrobial
Spectrum
Properties
First Nalidixic acid
Cinoxacin
Gram negative
(not Pseudomonas)
Poor serum and
tissue concentration.
Not for systemic
infections
Second Norfloxacin
Lomefloxacin
Enoxacin
Ofloxacin
Ciporfloxacin
Gram negative
(including
Pseudomonas),
Some Gram positive
Adequate serum and
tissue concentrations.
Good for systemic
infections.
Third Levofloxacin
Sparfloxacin
Gatifloxacin
Moxifloxacin
Same as for second-
gen. generation plus
expanded Gram
positive
Once-daily dosing
Fourth Trovafloxacin
Besifloxacin
Same as for third-
gen. plus broad
anaerobic coverage
Active against
anaerobic Gram-
positive and negative
General Structure and SAR
Ring 1
Ring 2
SAR of Quinolones: Rings
N
O
R
COOH
N
O
R
COOH
1
2
3
4
5
6
1
2
3
4
5
6
7
8
Substituted 1,4-dihydro-4-oxo-
3-pyridinecarboxylic
acid
Substituted quinolone 3-carboxylic
acid
Ø1,4-dihydro-4-oxo-3-pyridinecarboxylic acid portion is
necessary for the antibacterial activity.
ØThe pyridone ring (ring 1) must be attached to an aromatic ring
(ring 2), in which isosteric substitution of carbon with nitrogen
maintains the activity.
Ring 1
Ring 2
SAR: Isosteric substitutions on ring 2
ØIsosteric substitution of carbon with nitrogen
maintains the antibacterial activity.
N
N
O
R
COOH
1
2
3
4
5
6
7
8
N
N
O
R
COOH
1
2
3
4
5
6
7
8
N
N
O
R
COOH
1
2
3
4
5
6
7
8
N
N
O
R
COOH
1
2
3
4
5
6
7
8
Cinnolines 1,5-Naphthyridines
1,6-Naphthyridines 1,8-Naphthyridines
Ring 1
Ring 2
SAR: N1 alkyl substitutions
ØN1-Substitution is necessary for the antibacterial activity.
Small alkyl or cycloalkyl groups increase the antibacterial
activity in the following order: cyclopropyl >ethyl >methyl.
N
O
COOH
1
2
3
4
5
8
N
HN
F
7
6
N
O
COOH
1
2
3
4
5
8
CH3
N
HN
F
7
6
Ciprofloxacin Norfloxacin
SAR: N1 aryl substitutions
ØN1- Aryl substitution maintains the activity and
sometimes optimises it.
N
O
COOH
1
2
3
4
5
N
F
7
6
H2N
F
8
F
F
Trovafloxacin
SAR: Substitutions on C2, C5, C6, C7 & C8
N
O
R
COOH
1
2
3
4
5
6
7
8
ØSubstitution at C2 position decreases the activity remarkably or changes the
antibacterial characters.
ØSubstitution at C5 , C6 , C7 and at C8 has good effects on the activity.
ØC6 fluorine substitution increases the activity prominently, That’s why
quinolones are also called fluoroquinolones.
ØSubstituted or unsubstituted piperazinyl or pyrrolidinyl groups at C7 increase the
activity against P. aeroginosa (spectrum of activity)
Sparfloxacin
SAR: New ring (ring fusion) from N1 to C8
N
O
COOH
1
2
3
4
5
N
H3CN
F
7
6
O
CH3
H
8
Ofloxacin
Levofloxacin (-)S
N
X
O
CH3
COOH
O
O
X: N = Cinoxacin
X: CH = Oxolinic acid
1
3
4
5
7
8
2
6
ØRing fusion at N1and C8; C5 and C6; C6 and C7 or C7 and
C8 introduces active compounds:
Examples:
N N
N
O
CO2H
F
F
F
H
H
N
H
O
NH
H3C
H
O
H3C
NH2
Alatrofloxacin
Prodrug
N N
N
O
CO2H
F
F
F
H
H
H2N
Trovafloxacin
SAR: Amino Acid Substitutions
Alanines in alatrofloxacin are introduced to
improve drug transportation into cell/improve
absorption.
Removed from clinical use in 1999
Hepatotoxic
SAR of Toxicity and Side Effects
Can J Infect Dis. 2002 Jan;13(1):54-61.
Associated with CytP450 interactions
SAR Consideration: Metal Chelation
Ø The ability of these drugs to chelate polyvalent metal ions (Ca2+ , Mg2+ , Zn2+ , Fe2+,
Al3+ ), resulting in decreased solubility and reduced drug absorption.
Ø Causes kidney caliculi and crystalluria. (advice patients to drink lots of water)
Ø Chelation occurs between the metal and the 3-carboxylic acid and 4-keto groups.
Ø Agents containing polyvalent metals should be administered separately from the
quinolones.
Molecules. 2013 Sep; 18(9): 11153–11197.
A problem of chemical incompatibility of all Quinolones
Metal chelate
SAR of Toxicity: CNS toxicity
ØUnlike many anti-infective drugs, the quinolones can cause severe CNS effects
even after short-term use.
ØCNS side effects include: Tremor, sleep disorders, anxiety, and convulsions
because they cause GABA antagonism at the receptor.
ØBecause of low penetration to brain this toxicity is rare.
Flumequine (first generation)
Causes severe CNS side effects
Important Structural Modifications
Ø The most active of the
fluoroquinolones against
Gram-negative bacteria.
Ø A cyclopropyl substituent at
position 1 further increased
spectrum of activity.
Ø Replacement of the nitrogen
at position 8 with carbon
reduced adverse reactions
and increased activity against
S. aureus.
ØQuinolones were of little
clinical significance until
the addition of a fluoro
group to C6 greatly
increased the biologic
activity à it improved cell
wall penetration.
ØA piperazinyl ring at position 7,
was also beneficial for a variety
of pharmacokinetic reasons due
to the ability of the basic
substituent to form a zwitterion
with the carboxylic acid group at
position 3. This property appears
to radically enhance the ability of
these compounds to penetrate the
outer membrane of Gram negative
bacteria.
Critical for binding
Improves activity against a variety of organisms
(Spectrum of activity)
O
COOH
HO
OH
OH
O C
O
N
O
R1
F
R
Phase 2
Conjugation
Phase 1
CYP 450 (1A2)
N
O
COOH
R1
N
N
F
R2
HO
Potency
Pharmacophore
F
N
N
O
R1
O
OH
Cell penetration
Gyrase inhibition
Metabolism of Quinolones
Inactive
Reduced activity
Al-Zaytoonah University of Jordan
Faculty of Pharmacy
MedChem 3
Course #: 0201511
3 Credit Hours
Rima Hajjo, MS, PhD
r.hajjo@zuj.edu.jo
(3) Nitrofurans and Other Antimicrobial Agents
Ø Widely used oral antibacterial since WWII.
It is used for prophylaxis or treatment of
acute urinary tract infections when kidney
function is NOT impaired.
Ø Nausea and vomiting are common. Severe
side effects can be experienced when
using this drug (acute pulmonary
reactions, peripheral neuropathy,
hemolytic anemia, liver toxicity, and
fertility impairment).
Ø Inhibits DNA and RNA functions through
mechanisms that are not well understood.
There is little acquired resistance.
Nitroheteroaromatic compounds:
Ø Used orally for the treatment of
trichomoniasis, giardiasis, and Gardnerella
vaginalis infections. It has found increasing
use of late in the parenteral treatment of
anaerobic infections and for treatment of
pseudomembranous colitis due to
Clostridium difficile (opportunistic pathogen
that occasionally flourishes as a
consequence of broad-spectrum antibiotic
therapy, and infections can be life-
threatening). Important Antiparasitic agent.
Ø It is believed to be metabolically activated
by reduction of its nitro group to produce
metabolites that interfere with DNA and
RNA function.
1) 2)
O
C
H
O2N N N
O
O
Furazolidone
O
C
H
O2N N N
NH
O
O
Nitrofurantoin
O
C
H
N N N
NH
O
O
H
HO
Metabolism
Active form
O
C
H
N N N
NH
O
O
H
H
Extended conjugation of electrons
(Brown Color à urine discoloration)
Nitrofurans For UTIs
O
C
H
O2N X
For the management of chronic prostatitis.
Can cause hepatic injury
(Hepatic drug reactions are
more common in females for
unknown reasons).
Other examples:
acetaminophen, halothane,
nitrofurantoin, diclofenac, and
sulindac.
More on nitrofurans
Synthesis of Nitrofurantoin
Ø Replacing the furan ring with other five-membered rings such as thiophene and pyrrole
are less active).
Ø Replacing nitro with other isolelectric groups (e.g., sulfo, sulfamoyl, carboxyl or cyano)
reduce the antibacterial activity.
SAR:
thiophene pyrrole
furan
O
C
H
O2N X
O
O2N R
S
O2N R NH
O2N R
Protein N C
H
H
Methenamine (Hexamethylenetetramine)
For UTIs
Can form Schiff base with protein
(Hexamine)
Acidic media
Schiff base (imine)
Fosfomycin
Ø Fosfomycin (also known as phosphomycin) inhibits enolpyruvial transferase, an
enzyme catalyzing an early step in bacterial cell wall biosynthesis. Inhibition results in
reduced synthesis of peptidoglycan, an important component in the bacterial cell
wall.
Ø Fosfomycin is bactericidal against Escherichia coli and Enterobacter faecalis infections.
Ø It is used for treatment of uncomplicated urinary tract infections by susceptible
organisms.
For UTIs
Phenazopyridine
N
N
H2 NH2
N N
UTI Analgesic (does not have antibacterial properties)
Azo dye
bright red in color
Urinary analgesic – does not heal infections
For UTIs
Al-Zaytoonah University of Jordan
Faculty of Pharmacy
MedChem 3
Course #: 0201511
3 Credit Hours
Rima Hajjo, MS, PhD
r.hajjo@zuj.edu.jo
β-Lactam Antibiotics
- Penicillins
Agenda
Penicillins
What we need to know?
① Pharmacophore structure
② General Structures (highlighted in lecture)
③ SAR
④ How to improve: in vitro stability, administration route (oral is better),
stability towards β –lactamases, spectrum of activity (antibacterial activity)
⑤ Important Mechanisms of action, or reaction mechanisms.
Introduction: Antibiotics
What is an antibiotic?
1) It is a product of metabolism.
2) It is a synthetic product produced as structural analogue of naturally occurring
antibiotic.
3) It antagonizes the growth or survival of one or more species of microorganisms.
4) It is effective in low concentrations.
Modes of action:
1) Cell wall synthesis inhibitors
2) Cell membrane inhibitors
3) Protein synthesis inhibitors
4) Nucleic acids synthesis inhibitors
Major antibiotic classes that inhibit bacterial cell wall biosynthesis are:
1) β – Lactam antibiotics which include penicillins , cephalosporins and
carbapenems.
2) Monobactams.
3) Polypeptides.
Introduction: β – Lactam Antibiotics
ØAntibiotics that possess the β – Lactam ring (a
four-membered cyclic amide) such as
penicillins and cephalosporins.
ØThis group of antibiotics have:
1)Broad spectrum of antibacterial action
2)Potent and rapid bactericidal action against bacteria in the
growth phase.
3)Low frequency of toxic and other side effects in host.
Ring Types and Numberings of Clinically Available
Βeta-lactam Antibiotics
Memorize these!
The First β-Lactam Antibiotics: Penicillins
Ø Penicillins are the most widely used antibioticsin the World.
Ø Penicillins are antibacterial agents which inhibit bacterial
cell wall synthesis Discovered by Fleming from a fungal
colony (1928) shown to be non toxic and antibacterial. First
used on humans in 1942 (US, Streptococcal septicemia).
Ø The original fermentation-derived penicillins were
produced by growth of the fungus Penicillium
chrysogenum.
Penicillin G
Fermentation-derived
Active against G+ mainly
Biosynthesis of Penicillin
Two prototypes:
Memorize this structure for
6-APA in the blue box.
Benzyl penicillin: (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-
2-carboxylic acid. à IUPAC
1 2
3
4
5
7
Semisynthetic Penicillins
Then 6-APA is used to
synthesize other
“improved” penicillins
6-aminopenicillanic acid (6-APA) is
synthesized by hydrolyzing naturally
produced Penicillin G. Then 6-APA is
used to synthesize other penicillins
(semisynthetic because it relied on a
naturally-occurring precursor).
Synthesis of 6-APA from penicillin G
The 3D Shape of Penicillin
Ø Penicillin contains a highly
unstable bicyclic system
consisting of a four-membered β
–lactam ring fused to a five-
membered thiazolidine ring.
Ø The skeleton of the molecule
suggests that it is derived from
the amino acids cysteine and
valine, and this has been
established.
Ø The overall shape of the
molecule is like a half-open book,
as shown on the left.
Peptidoglycan Structure of Bacterial Cell Walls
is the Target for Penicillins
Ø β – Lactams bind at the active site of the transpeptidase enzyme that cross-links
the peptidoglycan strands at the positions indicated by arrows on the figure
above.
Ø It does this by mimicking the D-alanyl-D-alanine residues that would normally
bind to this site.
Mechanism of
Action of
Penicillins
The enzyme responsible for the cross-
linking reaction is known as the
transpeptidase enzyme .
Ø β – Lactams including
penicillin irreversibly
inhibit the enzyme
transpeptidase by
reacting with a serine
residue in the
transpeptidase à
inhibit cell wall
synthesis.
Ø Cell walls are essential
for bacteria to live.
Ø Cross-linking of
bacterial cell walls
inhibited by penicillin
Penicillin Mimics the Natural Substrate
Figure. Comparison of penicillin, 6-substituted penicillins, and acyl-d-Ala-d-Ala.
Mechanism of Transpeptidase Cross-linking and
Inhibition by Penicillins
β-Lactam Ring Acting as an Acylating Agent
Penicillin as a an Inhibitor for β-Lactamases
Specific Agents
Penicillins: Structure Activity Relationships (SAR)
Agenda:
ØSAR Considerations
ØStructural Modifications
ØProdrugs
ØDrugs that synergize with penicillins
Major SAR Considerations, Chemical and
Biological Instabilities
1) Hydrolysis by beta-lactamases (penicllinases in case
of penicillins)
2) Instability in basic media or in presence of
nucleophiles (e.g., OH-)
3) Instability in acids
1) Deactivation by Beta-lactamases
Mechanism of β-lactamase Deactivation of Penicillin:
You need to know this!
How to Reduce Sensitivity (increase resistance) to
Beta-lactamases?
Fig. β-Lactamase resistant/sensitive structural features.
2) Instability of Βeta-lactams to Nucleophiles
Hydrolysis in basic media
3) Instability of Penicillins in Acid
Hydrolysis
involves the C-6 side
chain.
Hydrolysis in Acidic media
Skip Mechanism just
remember how it is related to
the the C-6 side chain.
Ring Opening of Penicillins Leads to Loss of
Antibiotic Activity
Comparison of Tertiary Amide and β-
Lactam Carbonyl Groups
Structural Modifications to Solve the
Main Problems of Penicillins:
1) Oral Bioavailability
2) Deactivation by beta-lactamases
3) Spectrum of activity
4) PK properties/Prodrugs
SAR Rules
Making Penicillins Orally Active (i.e., resistant
to acidic hydrolysis)
How Improve Acid Stability to Allow Oral Administration
1) Pen V
2) Amino Penicillins
Making Penicillins β-Lactamase Resistant
Orally Active, Acid and β-Lactamase Resistant
Broad Spectrum Penicillins
1) Aminopenicillins
2) Carboxypenicillins
Hydrophilic Groups on the Side Chains of R on the
6th Position of the lactam Ring
Hydrophilic groups on the side
chain have little effect
on Gram-positive activity (e.g.
penicillin T) or cause
a reduction of activity (e.g.
penicillin N).
However, they lead to an
increase in activity against
Gram-negative bacteria
Prodrugs to Aid Absorption of Ampicillin
Through the Gut Wall
Mechanism of hydrolysis of prodrugs:
Polar Extended Ester for Penicillin G
Broad-spectrum Penicillins: Ureidopenicillins
Ø Ureidopenicillins (Figure above) are the newest class of broad-spectrum penicillins
and have a urea functional group at the α-position.
Ø Generally, they have better properties than the carboxypenicillins and have largely
replaced them in the clinic.
Synergism of Penicillins with Beta Lactamse Inhibitors
Clavulanic Acid
Synergism of Penicillins with Probencid
Probencid
Ø Probenecid is a moderately lipophilic carboxylic acid that can block
facilitated transport of penicillin through the kidney tubules and slows down
the rate at which penicillin is excreted.
Ø Probenecid also competes with penicillin for binding sites on albumin. As a
result, penicillin levels in the bloodstream are enhanced and the
antibacterial activity increases—a useful tactic if faced with a particularly
resistant bacterium.
Key Points: Penicillins
① Penicillins have a bicyclic structure consisting of a β-lactam ring fused to a
thiazolidine ring.
② The strained β-lactam ring reacts irreversibly with the transpeptidase enzyme
responsible for the final cross-linking of the bacterial cell wall.
③ Penicillin analogues can be prepared by fermentation or by a semi-synthetic
synthesis from 6-aminopenicillanic acid.
④ Variation of the penicillin structure is limited to the acylside chain or -OMe on 6th
position carbon of the beta lactam ring.
⑤ Penicillins can be made more resistant to acid conditions by incorporating an
electron-withdrawing group into the acyl side chain.
⑥ Steric shields can be added to penicillins to protect them from bacterial β-lactamase
enzymes.
⑦ Broad spectrum activity is associated with the presence of an α-hydrophilic group on
the acyl side chain of penicillin.
⑧ Prodrugs of penicillins are useful in masking polar groups and improving absorption
from the gastrointestinal tract.
⑨ Extended esters are used which undergo enzyme-catalysed hydrolysis to produce a
product which degrades spontaneously to release the penicillin.
⑩ Probenecid can be administered with penicillins to hinder the excretion of
penicillins.
Al-Zaytoonah University of Jordan
Faculty of Pharmacy
MedChem 3
Course #: 0201511
3 Credit Hours
Rima Hajjo, MS, PhD
r.hajjo@zuj.edu.jo
β-Lactam Antibiotics
- Cephalosporins
Agenda
ØCephalosporins
What we need to know?
① Pharmacophore structure
② General Structures (highlighted in lecture)
③ SAR
④ How to improve: in vitro stability, administration route (oral is better),
stability towards β –lactamases, spectrum of activity (antibacterial activity)
⑤ Important Mechanisms of action, or reaction mechanisms.
Cephalosporin C
Amino Adipic Acid
IUPAC NAME:
(6R,7R)-3-[(Acetyloxy)methyl]-7-{[(5R)-5-
amino-5-carboxypentanoyl]amino}-8-oxo-5-
thia-1-azabicyclo[4.2.0]oct-2-ene-2-
carboxylic acid
1
2
3
4
5
6
7
8
Mechanism of Inhibition of
Transpeptidase by Cephalosporins
Biosynthesis of Cephalosporins
Building Blocks/Precursors
Positions for Possible Modification
of Cephalosporin C.
The shading indicates positions which can be varied
2
3
1
4
5
6
8
First Generation Cephalosporins
thiophene
Acetyloxy group at position 3 is
readily hydrolyzed by esterase
enzymes to give the less active
alcohol.
Metabolic Hydrolysis of Cephalothin:
Cephalothin
First Generation Cephalosporins
Ø Cephaloridine exists as a zwitterion and is soluble in water, but, like most first
generation cephalosporins, it is poorly absorbed through the gut wall and has to be
injected. Pyridinium at C3 in Cephaloridine is metabolically stable. The pyridine can
still act as a good leaving group for the inhibition mechanism, but is not cleaved by
esterases.
Ø The Me at C3 in Cefalexin increases absorption through the gut and is stable to
metabolism à orally bioavailable.
Orally absorbed
Cephaloridine Cefalexin
Other First Generation Cephalosporins
Modifications on two positions: R and X
Cefazolin Cephalexin Cefadroxil
Parenteral Oral
Second Generation Cephalosporins: Cephamycins
Ø Cephamycins contain a methoxy substituent at position 7, which has proved
advantageous. Modification of the side chain gave cefoxitin, which showed a broader
spectrum of activity than most first-generation cephalosporins. This is due to greater
resistance to β–lactamase enzymes, which may be due to the steric hindrance
provided by the methoxy group.
Ø Cefoxitin showed good metabolic stability to esterases owing to the presence of the
urethane group at position 3, rather than an ester.
Urethrane group
Urethrane group
Cephamycin C Cefoxitin
Second Generation: Oximinocephalosporins
Ø Oximinocephalosporins has been a major advance in cephalosporin research. These
structures contain an iminomethoxy group at the α –position of the acyl side chain,
which significantly increases the stability of cephalosporins against the β -lactamases
produced by some organisms (e.g. Haemophilus influenza ).
Ø Increased resistance to β -lactamases and mammalian esterases (like cefoxitin). Unlike
cefoxitin, cefuroxime retains activity against streptococci and, to a lesser extent,
against staphylococci.
Urethrane group
Examples: Second Generation
Modifications on 4 positions: R, X, Y and Z
Parenteral
Cefuroxime
Cefotetan
Cefoxitin
Cefaclor Cefprozil
Oral
Third Generation Cephalosporins
ØAminothiazolering in Ceftazidime enhances the penetration of cephalosporins
through the outer membrane of Gram-negative bacteria, and may also increase affinity
for the transpeptidase enzyme. As a result, third-generation cephalosporins containing
this ring have a marked increase in activity against these bacteria.
Third Generation Cephalosporins
Ø Other 3rd generation compounds: cefotaxime, ceftizoxime, and ceftriaxone, with
different substituents at position 3 to vary the pharmacokinetic properties. They play a
major role in antimicrobial therapy because of their activity against Gram-negative
bacteria, many of which are resistant to other β –lactams.
Ø As such infections are uncommon outside hospitals, physicians are discouraged from
prescribing these drugs routinely and they are viewed as ‘reserve troops’ to be used for
troublesome infections which do not respond to the more commonly prescribed β -
lactams.
(R)
Iminomethoxy
Aminothiazole
Examples: Third Generation
Third Generation Cephalosporins
Fourth Generation Cephalosporins
Ø They are zwitterionic compounds having a positively charged substituent at
position 3 and a negatively charged carboxylate group at position 4. This property
appears to radically enhance the ability of these compounds to penetrate the outer
membrane of Gram negative bacteria.
Ø They are also found to have a good affinity for the transpeptidase enzyme and a low
affinity for a variety of β-lactamases.
Iminomethoxy
Aminothiazole
Special Considerations for Oximes on the
7th position
Ø Z-oxime is preferred over the E-oxime
Ø Stability toward β-lactamase can be increased
around 100-fold with the addition of
methoxyoxime. Z-oxime is nearly 20,000-fold more
stable than the E-oxime
Prodrug Cephalosporins
N
S
O
H
H
HN
O OCONH2
O
NOCH3
O O
O
CH3
CH3
O
N
S
O
H
HN
O OCH3
NOCH3
H
N
S
H2N
O O
CH3
O
O
O
CH3
CH3
Cefuroxime axetil
Cefpodoxime proxetil
Another Prodrug: “Fifth-generation”
Cephalosporin
Has activity against various strains of MRSA and multi-resistant
Streptococcus pneumonia (MDRSP).
Ceftaroline fosamil
Newest Cephalosporin
The 1,3-thiazole ring is
thought to be
important for its
activity against MRSA.
Resistance to Cephalosporins
Ø The activity of a specific cephalosporin against a particular bacterial cell is
dependent on the same factors as those for penicillins. i.e. the ability to reach the
transpeptidase enzyme, stability to any β -lactamases which might be present, and
the affinity of the antibiotic for the target.
Ø For example, most cephalosporins (with the exception of cephaloridine) are stable
to the β -lactamase produced by S. aureus and can reach the transpeptidase
enzyme without difficulty. Therefore, the relative ability of cephalosporins to inhibit
S. aureus comes down to their affinity for the target transpeptidase enzyme.
Agents such as the cephamycins and ceftazidime have poor affinity, whereas other
cephalosporins have a higher affinity.
Ø The MRSA organism contains a modified transpeptidase enzyme ( PBP2a)
for which both penicillins and cephalosporins have poor affinity.
Key Points: Cephalosporins
Ø Cephalosporins contain a strained β-lactam ring fused to a dihydrothiazine ring.
Ø In general, first-generation cephalosporins offer advantages over penicillins in
that they have greater stability to acid conditions and β-lactamases, and have a
good ratio of activity against Gram-positive and Gram-negative bacteria.
However, they have poor oral availability and are generally lower in activity.
Mainly reserved for parenteral formulations.
Ø Variation of the 7-acylamino side chain alters antimicrobial activity, whereas
variation of the side chain at position 3 predominantly alters the metabolic and
pharmacokinetic properties of the compound. Introduction of a methoxy
substitution at C-7 is possible, making compounds more resistant to beta
lactamases.
Ø Semisynthetic cephalosporins can be prepared from 7-aminocephalosporanic
acid (7-ACA). 7-ACA is obtained from the chemical hydrolysis of natural
cephalosporins.
Key Points: Cephalosporins
Ø Deacetylation of acetyl groups on 3rd position of cephalosporins occurs
metabolically to produce inactive metabolites. Metabolism can be blocked
by replacing the susceptible acetoxy group with metabolically stable
groups.
Ø A methyl substituent at position 3 is good for oral absorption but bad for
activity unless a hydrophilic group is present at the α-position of the acyl
side chain.
Ø Cephamycins are cephalosporins containing a methoxy group at position 7.
Ø Oximinocephalosporins have resulted in several generations of
cephalosporins with increased potency and a broader spectrum of activity,
particularly against Gram-negative bacteria.
Al-Zaytoonah University of Jordan
Faculty of Pharmacy
MedChem 3
Course #: 0201511
3 Credit Hours
Ø Aminoglycosides
Ø Aminoglycosides are irreversible inhibitors of protein
synthesis.
Ø They are active against aerobic gram negative bacilli and
staphylococci.
Ø The initial event is passive diffusion via channels across the
outer membrane. Drug is then actively transported across the
cell membrane into the cytoplasm by an oxygen- dependent
process, which is coupled to a proton pump.
Ø Low extracellular pH and anaerobic conditions inhibit
transport by reducing the gradient. Transport may be
enhanced by cell wall-active drugs, such as penicillins.
Ø They bind irreversibly to a receptor protein on the 30S ribosomal
subunit and blocks the formation of a complex that includes mRNA,
formylmethionine, and tRNA. Protein synthesis is inhibited by
aminoglycosides.
(1) They interfere with the initiation complex of peptide formation.
(2) They induce misreading of mRNA, which causes incorporation of
incorrect amino acids into the peptide, resulting in a nonfunctional
or toxic protein.
Ø They are strongly basic compounds that exist as poly cations at physiological
pH. Their inorganic acid salts are very soluble in water (as sulfates).
Ø Solutions of the aminoglycoside salts are stable to autoclaving.
Ø The high water solubility of the aminoglycosides contributes to their
pharmacokinetic properties. They distribute well into most body fluids but not
into the central nervous system, bone, fatty or connective tissues.
Ø They tend to concentrate in the kidneys and are excreted by glomerular
filtration. Metabolism of aminoglycosides in vivo apparently does not occur.
O
O
OH
NH 2
H2N
O
CH 2
OH
H2N
OH
OH
O
OH
CH 2
NH 2
HO
HO
Kanamycin C
Ø Aminoglycosides structures consist of
amino sugars linked glycosidically to
1,3-diaminoinositol.
The antibacterial spectrum (e.g. kanamycin) was limited by resistance in
many species of bacteria, this is due to the presence of R factors which
direct the synthesis of a new family of enzymes that inactivate
aminoglycoside by three separate mechanisms: acetylation, adenylation
and phosphorylation.
SAR (Ring I (A))
ØRing I (Ring A) is crucial for antibacterial activity.
ØIt is the target for enzymatic inactivation and so any change in
the substitution patterns can lead to significant changes in
antibacterial activity.
ØThe number and location of amino functions in ring I can affect
SAR.
Kanamycin B
ØKanamycin B > Kanamycin A > kanamycin C , thus indicating the greater
importance of the 6'-amino group over the the 2‘-amino group.
ØAcylation of either the 6'- or 2'- amino groups lead to a severe decrease in
potency.
Ø6'- position C- or N- methylation can lead to retention, or even improvement of
potency, 6'-N- methylation can have a beneficial effect by preventing
inactivation via 6- acetyltransferase enzymes.
O
O
OH
NH 2
OH
O NH 2
H2N
OH
OH
O
OH
HO
H2N
HO
H
H
S S
R
R
R
R
R
S
S S
R
R
R
S
S
Kanamycin A
O
O
OH
NH 2
H2N
O
CH 2
OH
H2N
OH
OH
O
OH
CH 2
NH 2
HO
HO
Kanamycin C
Kanamycin B
6’
Ø Replacement of hydroxyl groups by hydrogen can lead to an
improved potency and spectrum of action.
Ø Conversion of Kanamycin B to its 3'- deoxy or 3', 4’ dideoxy
derivative (Tobramycin or Dibekacin respectively) leads to a
substantial improvement in activity against Pseudomonas
aeurginosa and a small improvement against other species.
O
O
OH
NH 2
OH
O NH 2
H2N
OH
OH
O
NH 2
H2N
HO
H
H
S S
S
R
R
R
R
S
S S
R
R
R
S
Tobramycin
Kanamycin B
Ø Unsaturation in ring I of Kanamycin B: by replacing the 3',4'-
hydroxyl groups by a double bond diminished activity,
Ø While introduction of a 4',5'- double bond gives a potent
derivative .
NHEt
NHMe
Me
O
O
OH
OH
O
H2N
OH
O
NH 2
H2N
H
H
S
R
R
S
R
R
R
S
R
S
R
Netilmicin
SAR (Ring II (B))
Ø The most important modification to the 2-deoxystreptamine
ring has been acylation of the 1-amino with 2- hydroxyl-4-
aminobutyric acid (HABA) as in Amikacin, which improves
activity against resistant bacteria.
Ø Methylation of 1,3-diamino groups gives Spectinamine ring.
O
O
N
H
OH
HO
O
H2N
O
H2N
OH
OH
OH
O
OH
NH 2
HO
H2N
HO
H
H
S
S
R
S
R
R
R
S
S
S
S
R
R
R
S
S
Amikacin
2-deoxystreptamine ring
improves
activity against
resistant
bacteria.
SAR (Ring III (C))
Ø When ring III is a pyranose ring, removal or methylation of the 2"-
hydroxyl group has led to a considerable decrease in antibacterial
activity, although activity is retained on replacement of the 2"-
hydroxyl by an amino group, as in Seldomycin-5.
Ø The 3"-group may be a primary or secondary amino group.
Ø The 4"-hydroxyl may be axial or equatorial.
Ø Several modifications at the 6"-position have led to a retention of
antibacterial activity.
Ø When ring III is a furanose ring, the 3"-hydroxyl may be
substituted as in Neomycin and Paromomycin.
Ø Possession of a fourth ring, as in Neomycin, generally
leads to increased potency.
O
O
O
H2N
NH 2
OH
HO
O
NH 2
HO
HO
HO
O
OH
O
NH 2
OH
NH 2
OH
H
H H
R
S R
S
R
S
R
R
S
R
S
R S
R
R
R
S
R
S
Paromomycin
3
Substituted OH
With a 4th ring increases activity
Me
NHMe
OHC O
O
O
O
OH
OH
OH
OH
N
H
HO
OH
HO
NH
NH 2
N
H
NH
NH 2
H
H
R S
R
R
S
S
S
S
R
R
S
R
R
S
R
Streptomycin
Streptidine ring
Incompatibilities
With beta-lactams
Al-Zaytoonah University of Jordan
Faculty of Pharmacy
MedChem 3
Course #: 0201511
3 Credit Hours
Rima Hajjo, MS, PhD
r.hajjo@zuj.edu.jo
Macrolide Antibiotics
Macrolides
Intramolecular ketal formation in
Erythromycin.
Responsible for
basic properties
of macrolides
1
6
9
2
The problem!
Macrocyclic lactone
Aglycone
Glycon
Ø Macrolides are a class of natural and
semisynthetic antibiotics.
Ø For bacterial and fungal infections.
Ø Mechanism of action: inhibit protein
synthesis.
Ø Acid sensitive
12
Mechanism of acid catalyzed intramolecular ketal
formation with Erythromycin
1
6
9
2
Just remember the simple basics:
OH on position 6 will do a
nucleophilic attack on carbonyl
carbon on position 9.
Ketal is inactive! (that’s’ bad)!
Methods for protecting erythromycin from acid
catalyzed ketal formation
1. The hydroxyl groups are changed to
methoxy groups as in clarithromycin
which has improved acid-stability and
oral absorption.
2. Increasing the member atoms of the
macrolide (e.g. 15-membered ring of
azithromycin).
3. Formation of salts with fatty acids
SAR of Macrolides EM: Erythromycin
CAM: Clarithromycin
If R1 is phenyl: carbazate
If R1 is alkyl: carbamate
1
6
9
2
10
Examples
Erythromycin
ØExample: isolated from Streptomyces erythreus.
ØOne of the safest antibiotics in clinical use.
ØThe structure consists of a 14-membered
macrocyclic lactone ring with a sugar and an amino
sugar attached. The sugar residues are important for
activity.
Ø Erythromycin binds to the 50S subunit of bacterial ribosomes. And, it inhibits
translocation.
Ø Erythromycin & Chloramphenicol bind to the same region of the ribosome, they
shouldn’t be administered together as they will compete with each other and be less
effective.
Ø Erythromycin is unstable to stomach acids but can be taken orally in a tablet form
(coated tablet).
Ø The acid sensitivity is due to the presence of a ketone and 2 alcohol groups which are
set up for the acid-catalyzed intramolecular formation of a ketal.
Chemical Modifications to Increase the Stability of
Macrolide Antibiotics
Ø To prevent ketal formation,
protection of hydroxyl groups was
applied in clarithromycin.
Ø The methoxy analogue is more
stable to gastric juice and has
improved oral absorption.
Ø Another method of increasing acid
stability is to increase the size of
the macrocycle ring.
Ø Azithromycin contains a 15-
membered macrocycle where an N-
methyl group is incorporated into
the macrocycle (Erythromycin has a
14-memebered macrocyclic ring)
The two hydroxyl groups that cause
the intramolecular ketal formation
in erythromycin have been masked,
one as OCH3, and the other as part
of the carbamate ring.
The cladinose sugar in
erythromycin has been
replaced with a keto-group
A carbamate ring has
been fused to the
macrocyclic ring.
Telithromycin
Telithromycin: A semi-synthetic derivative of erythromycin
3
3
6
12
9
v
v
Chemical Modifications to Increase the Stability
of Macrolide Antibiotics
Spectrum of Activity
ØThe macrolides are bacteriostatic antibiotics with a
broad spectrum of activity against many Gram positive
aerobic bacteria (Clarithro > Erythro > Azithro), and
Gram negatives aerobes (Azithro > Clarithro >
Erythro).
ØCurrently available macrolides are well tolerated, orally
available.
ØWidely used to treat mild-to-moderate infections.
ØSeveral macrolidem antibiotics have been linked to liver
injury.
Water Solubility
Ø The free bases of erythromycin and its analogs are moderately soluble in water
Ø Water solubility can be improved by salt formation with some organic acids such
as glucoheptonic and lactobionic acids to be used for parenteral administrations
Ø Water solubility can be decreased if salts are prepared with fatty acids as stearate,
estolate and laurylsulfate salts.
Ø Erythromycin stearate is a very insoluble salt form of erythromycin.
The water insolubility helps:
1) To increase stability toward acids
2) To increase oral absorption
3) To mask bitter taste
Al-Zaytoonah University of Jordan
Faculty of Pharmacy
MedChem 3
Course #: 0201511
3 Credit Hours
Rima Hajjo, MS, PhD
r.hajjo@zuj.edu.jo
Antibiotics that Impair Protein Synthesis
Ø Lincosamides
Ø Chloramphenicol
Lincosamides - Introduction
Ø The lincosamides contain an unusual 8-carbon sugar, a thiomethyl amino-
octoside (O -thio-lincosamide), linked by an amide bond to an n -propyl
substituted N -methylpyrrolidylcarboxylic acid (N -methyl-n -propyltrans-
hygric acid).
Ø Lincosamides are weakly basic and form clinically useful hydrochloric acid
salts.
Ø They are chemically distinct from the macrolide antibiotics but possess
many pharmacologic similarities to them.
Ø The lincosamides are bacteriostatic, they bind to 50S ribosomal
subparticles at a site partly overlapping with the macrolide site and are
mutually cross-resistant with macrolides and work through essentially the
same molecular mechanism of action.
Ø The lincosamides undergo extensive liver metabolism resulting primarily
in N -demethylation.
Ø The N -desmethyl analog retains biologic activity.
Lincosamides
SN2 Reaction and
inversion of
stereochemistry
Methyl 6,8-dideoxy-6-(1-methyl-
trans-4-propyl-L2-
pyrolidinecarboxamido)-1-thio-D-
erythro-α-D-galactooctopyranoside
Lincomycin (Lincocin)
ØLincomycin is a natural product isolated from fermentations of
Streptomyces lincolnensis.
ØIt is active against gram-positive organisms including some
anaerobes.
ØIt is generally reserved for penicillin-allergic patients due to the
increased risk of pseudomembranous colitis.
ØIt also serves as the starting material for the synthesis of
clindamycin (by an SN-2 reaction that inverts the R
stereochemistry of the C-7 hydroxyl to a C-7 S-chloride).
Clindamycin (Cleocin)
ØThe substitution of the chloride for the
hydroxy group consequently makes
clindamycin more bioactive and lipophilic
than lincomycin, and thus, it is
betterabsorbed following oral administration.
ØIt is about 90% absorbed when taken orally.
ØClindamycin has a clinical spectrum rather
like the macrolides, although it distributes
better into bones.
ØClindamycin works well for gram-positive
coccal infections, especially in patients
allergic to β-lactams, and also has generally
better activity against anaerobes.
Clindamycin – cont.
Ø The most severe of these (black box warning) is pseudomembranous colitis caused
Clostridium difficile, an opportunistic anaerobe. Its overgrowth results from
suppression of the normal flora whose presence otherwise preserves a healthier
ecologic balance. The popularity of clindamycin in the clinic has decreased even
though pseudomembranous colitis is comparatively rare and is also associated with
several other broad-spectrum antibiotics.
Ø A less common side effect is exudative erythema multiform (Stevens-Johnson
syndrome). Clindamycin has excellent activity against Propionibacterium acnes
when applied topically.
Ø A very water-insoluble palmitate hydrochloride prodrug of clindamycin is also
available (lacks bitter taste).
Ø However, as with lincomycin, it is associated with GI complaints (nausea, vomiting,
cramps, and drug-related diarrheas).
Spectrum of Activity
Lincosamideshave an unusual antimicrobial spectrum,
being active against only Gram-positive and not Gram-
negative aerobic bacteria but widely and potently
active against anaerobic bacteria and some protozoa.
Chloramphenicol
Chloramphenicol is an antibiotic useful for the treatment of a number of
bacterial infections:
1) Eye ointment to treat conjunctivitis
2) Orally or by injection into a vein, it is used to treat meningitis, plague,
cholera, and typhoid fever.
Al-Zaytoonah University of Jordan
Faculty of Pharmacy
MedChem 3
Course #: 0201511
3 Credit Hours
Rima Hajjo, MS, PhD
r.hajjo@zuj.edu.jo
Antibacterial Agents that Impair Protein Synthesis
Ø Tetracyclines and Glycylcyclines
Introduction
Ø Tetracyclines are antibiotcs isolated from Streptomyces aureofaciens (aureo
meaning golden color).
Ø They are broad spectrum, act on Gram-positive, Gram-negative, aerobic and
anerobic bacteria.
Ø most widely prescribed after penicillins.
Ø Bacteriostatic antibiotics.
Ø Inhibit protein synthesis by binding to the 30S subunit of ribosomes and
preventing aminoacyl-tRNA from binding.
Ø They inhibit protein synthesis in bacteria.
Ø Selectivity is due to the ability of bacterial cells to concentrate these agents
faster than human cells.
Ø In the case of Gram-negative bacteria, tetracyclines cross the outer
membrane by passive diffusion through the porins. Passage across the inner
membrane is dependent on a pH gradient, which suggests that a proton-
driven carrier is involved.
Introduction: Tetracyclins in Medical Use
Tetracyclins: General Structure
This family of antibiotics is characterized by a highly functionalized,
partially reduced naphthacene (four linearly fused six-membered rings)
ring system from which both the family name and numbering system are
derived.
Schematic representation of the primary binding site for a tetracycline and the sugar
phosphate groups of 16S rRNA, which also involves a magnesium ion and the critical
functional groups on the “southern” and “eastern” face of the tetracycline.
Mechanism of Action
Chemical Instabilities
I. Acid-catalyzed Instabilities of Tetracyclins
II. Base-catalyzed Instabilities of Tetracyclins
III. Chelation with metals
IV. Phototoxicity
I. Acid-catalyzed Instabilities of Tetracyclinns:
Dehydration
A tertiary and benzylic
hydroxyl group at C6 is
unstable.
This degradation product is toxic to the kidneys and produces a
Fanconi-like syndrome that, in extreme cases, has been fatal
Tetracyclines that have
no C-6-hydroxyl
groups,
such as minocycline
and doxycycline,
cannot undergo
dehydration and thus
are completely free of
this toxicity.
Secondary alcohol on
C6 is more resistant to
dehydration.
II. Base-catalyzed instabilities of Tetracyclins
Inactive lactone-derivative
Active
III. Metal Chelation
Inactive
Metal Chelation
ØChelation is an important feature of the chemical and clinical properties of the
tetracyclines. The acidic functions of the tetracyclines are capable of forming
salts through chelation with metal ions.
ØThe salts of polyvalent metal ions, such as Fe2+, Ca2+, Mg2+, and Al3+, are all
quite insoluble at neutral pHs, insolubility is not only inconvenient for the
preparation of solutions, but also interferes with blood levels on oral
administration.
ØConsequently, the tetracyclines are incompatible with coadministered
multivalent ion-rich antacids, and concomitant consumption of food rich in
calcium (ions are contraindicated 1 hour before or 2 hours after the
tetracyclines).
Tetracyclin-Induced Teeth Discoloration
ØBones and teeth are calcium-rich structures at nearly neutral pHs and
so accumulate tetracyclines in proportion to the amount and duration
of therapy when bones and teeth are being formed. Because the
tetracyclines are yellow, this leads to a progressive and essentially
permanent discoloration in which, in advanced cases, the teeth are
even brown.
ØThis is cosmetically unattractive but does not seem to be deleterious
except in extreme cases where so much antibiotic is taken up that the
structure of bone is mechanically weakened. To avoid this,
tetracyclines are not normally given to children or pregnant women.
The keto-enol tautomerism of ring A at C1 and C3 is a
common feature to all biologically active tetracyclines,
derivatives at C1 and C3 results blocking this system and
loss of antibacterial activity
SAR of Ring A
Ø The amide is best left unsubstituted.
Ø N-monoalkylation results in prodrug which can be
hydrolyzed in vivo to parent compound.
SAR of Ring A
SAR of Ring A
Ø The α-H at C-4a position of is necessary for useful antibacterial activity.
Ø The α-C-4 dimethyl amino substituent supports the keto-enolic character of
the A-ring.
Ø Loss of activity occurs if dimethyl amino group is:
-having reversed stereochemistry
-being replaced with hydrazone (-N-N=C), oxime (-N-OH) or hydroxyl (-OH)
The basic function is the
C-4-a-dimethylamino moiety.
SAR of Ring A
Larger alkyl group àdisturb C1-C2-
C3 tautomerism àreduce
antibacterial activity e.g.
Rolitetracyline is a prodrug which
is more water soluble
SAR of Ring B: C5 and C5a
ØAll natural active tetracyclines have
unsubstituted C5 (i.e. R4=H).
ØAlkylation of the C-5 hydroxyl group (i.e.
R4=CH3) results in loss of activity.
ØSubstitution with C-5 α-hydroxyl group (i.e. R4=OH) give potent compound
(e.g. oxytetracycline).
ØCan be esterified to small alkyl esters to form semisynthetic tetracyclines
which releases oxtetracycline in vivo (prodrug).
SAR: ring C (position C6)
ØThe mostly used ring to prepare semi-synthetic
analogues.
ØUsually, natural tetracyclins have α-methyl group
and α-β-hydroxyl group at this position.
ØThe C6 methyl group contributes little to the activity of tetracycline.
ØThe C6 position is tolerant to a variety of substituents.
ØDemeclocyclin is a naturally occurring C6 α-demethylated Chlortetracycline
with an excellent activity.
ØUnstable in acidic and basic media.
SAR of Ring C: Modifications
at C6
Ø6-Deoxytetracyclines possess important chemical and
pharmacokinetic advantages 6-oxy tetracyclins. More
stable under both acidic and basic media.
Ø Unstable in strongly acidic conditions. Suffers prototropic rearrangement to
the anhydrotetracycline in acid.
Ø Stable in basic media: stable to -ketone cleavage followed by lactonization to
the isotetracycline in base.
ØReduction of the C6 hydroxyl group also dramatically changes the solubility
properties of tetracyclines. This effect is reflected in significantly higher
oil/water partition coefficients of the 6-deoxytetracyclines than of the
tetracyclins.
6
Make a secondary alcohol at
position C6
(Eliminate CH3 at C6)
Eliminate OH group at position C6
Summary: How to Increase the Stability of
Tetracyclins?
Tetracycline
Minocycline
SAR: Lipophilic Tetracyclins (6-deoxy cps.)
ØThe greater lipid solubility of the 6-deoxy compounds (such
as doxycycline and minocycline has important
pharmacokinetic consequences (absorption, distribution and
protein binding).
ØPK properties of Doxycycline and minocycline:
(1) Absorbed more completely following oral administration
(2) Exhibit higher fractions of plasma protein binding
(3) Have higher volumes of distribution and lower renal
clearance rates than the corresponding 6-oxytetracyclins.
SAR of rings C & D: Effect on Half lives (t1/2)
Derivatives have been
synthesized without
6-OH, these agents
were more stable,
lipophilic and long
lasting than those
with 6-OH group.
Long lasting
Longer t1/2
SAR of Ring D and Structure-Toxicity Relationships
ØRing D must be aromatic.
ØC7-Cl causes phototoxicity.
Ø Certain tetracyclines, most notably those with a C7-chlorine,
absorb light in the visible region, leading to free radical
generation and potentially causing severe erythema to
sensitive patients on exposure to strong sunlight.
SAR of ring D: C7 and C9
SAR of ring D: C7 and C9
SAR Rules:
Activity is lost by:
- Double bond between 5a and 11a
- Aromatization of ring C
Ring D must be aromatic
Metabolism
Spectrum of Activity and Clinical Use
ØAntimicrobial spectra of various tetracyclines are similar.
ØThey have the broadest spectrum of activity, on both gram +,
gram – and atypical bacteria.
ØDue to resistance and toxicity, penicillins replaced them in many
infections, especially the respiratory infections.
ØTetracyclines are still used in rickettsia, Chlamydia, mycoplasma
and acne infections.
ØSome of them have antiparasitic properties such as the use of
Doxycycline in the treatment and prophylaxis of malaria.
ØThey have bacteriostatic action, not recommended in life
threatening infections such as septicemia, endocarditis and
meningitis.
Mechanism of Uptake and Resistance to
Tetracyclins
Glycylcyclines
ØThese tetracycline analogues are specifically designed to
overcome two common mechanisms of tetracycline resistance: (1)
resistance mediated by acquired efflux pumps and/or (2)
ribosomal protection.
Ø Glycylcyclines are a class of
antibiotics derived from
tetracycline.
Ø Tigecycline is the only
glycylcycline approved for
antibiotic use.
Ø Broad spectrum including
MRSA.
Tigecycline
9-tert -butylglycylamido
derivative of minocycline.
Glycine

More Related Content

What's hot

Factors affecting protein drug binding and its kinetics
Factors affecting protein drug binding and its kineticsFactors affecting protein drug binding and its kinetics
Factors affecting protein drug binding and its kinetics
Malla Reddy College of Pharmacy
 
Factors affecting biotransformation of drugs
Factors affecting biotransformation of drugsFactors affecting biotransformation of drugs
Factors affecting biotransformation of drugs
Zubia Arshad
 
Gastric Proton pump inhibitors
Gastric Proton pump inhibitorsGastric Proton pump inhibitors
Gastric Proton pump inhibitors
kencha swathi
 
Herbal excipients
Herbal excipientsHerbal excipients
Herbal excipients
Dr Priyanka Goswami
 
kinetics of protein binding.pptx
kinetics of protein binding.pptxkinetics of protein binding.pptx
kinetics of protein binding.pptx
GitanjaliMehetre1
 
Drug Metabolism and Related Drug Interactions
Drug Metabolism and Related Drug InteractionsDrug Metabolism and Related Drug Interactions
Drug Metabolism and Related Drug Interactions
Imhotep Virtual Medical School
 
Biodynamic agriculture hdt 1st unit 2nd chapter
Biodynamic agriculture hdt 1st unit 2nd chapterBiodynamic agriculture hdt 1st unit 2nd chapter
Biodynamic agriculture hdt 1st unit 2nd chapter
Prof.(Dr.)Kirtimaya Mishra
 
Hearbs drugs interaction
Hearbs drugs interactionHearbs drugs interaction
Hearbs drugs interaction
Bidhan Mahajon
 
Factors Influencing the Cultivation of Medicinal Plants
Factors Influencing the Cultivation of Medicinal PlantsFactors Influencing the Cultivation of Medicinal Plants
Factors Influencing the Cultivation of Medicinal Plants
Dr K SUDHEER KUMAR KANDIBANDA
 
Quinolones.pptx
Quinolones.pptxQuinolones.pptx
Quinolones.pptx
Ayushi Dogne
 
Appetite stimulant and
Appetite stimulant   andAppetite stimulant   and
Appetite stimulant and
pctebpharm
 
Pharmacognosy Families By AAA Arslan, Ayyaz, Asad
Pharmacognosy Families By AAA Arslan, Ayyaz, AsadPharmacognosy Families By AAA Arslan, Ayyaz, Asad
Pharmacognosy Families By AAA Arslan, Ayyaz, Asad
Muhammad Latif
 
Respiratory stimulants
Respiratory stimulants Respiratory stimulants
Respiratory stimulants
Ameena Kadar
 
Absorption of drugs
Absorption of drugs Absorption of drugs
Absorption of drugs
Danish Kurien
 
Herb drug & herb-food interactions
Herb drug & herb-food interactionsHerb drug & herb-food interactions
Herb drug & herb-food interactions
Mahewash Sana Pathan
 
Herbs as raw materials
Herbs as raw materialsHerbs as raw materials
Herbs as raw materials
Professor
 
Herbal drug industry (unit 5)
Herbal drug industry (unit 5)Herbal drug industry (unit 5)
Herbal drug industry (unit 5)
Mohammad Khalid
 
4.3 thyroid hormones analogues and their inhibitors
4.3 thyroid hormones  analogues and their inhibitors4.3 thyroid hormones  analogues and their inhibitors
4.3 thyroid hormones analogues and their inhibitors
Arunachalam Muthuraman
 
drug interaction
drug interactiondrug interaction
drug interaction
Zahra Khan
 
Biotransformation-pharmacology
Biotransformation-pharmacologyBiotransformation-pharmacology
Biotransformation-pharmacology
DHINESHKUMAR V
 

What's hot (20)

Factors affecting protein drug binding and its kinetics
Factors affecting protein drug binding and its kineticsFactors affecting protein drug binding and its kinetics
Factors affecting protein drug binding and its kinetics
 
Factors affecting biotransformation of drugs
Factors affecting biotransformation of drugsFactors affecting biotransformation of drugs
Factors affecting biotransformation of drugs
 
Gastric Proton pump inhibitors
Gastric Proton pump inhibitorsGastric Proton pump inhibitors
Gastric Proton pump inhibitors
 
Herbal excipients
Herbal excipientsHerbal excipients
Herbal excipients
 
kinetics of protein binding.pptx
kinetics of protein binding.pptxkinetics of protein binding.pptx
kinetics of protein binding.pptx
 
Drug Metabolism and Related Drug Interactions
Drug Metabolism and Related Drug InteractionsDrug Metabolism and Related Drug Interactions
Drug Metabolism and Related Drug Interactions
 
Biodynamic agriculture hdt 1st unit 2nd chapter
Biodynamic agriculture hdt 1st unit 2nd chapterBiodynamic agriculture hdt 1st unit 2nd chapter
Biodynamic agriculture hdt 1st unit 2nd chapter
 
Hearbs drugs interaction
Hearbs drugs interactionHearbs drugs interaction
Hearbs drugs interaction
 
Factors Influencing the Cultivation of Medicinal Plants
Factors Influencing the Cultivation of Medicinal PlantsFactors Influencing the Cultivation of Medicinal Plants
Factors Influencing the Cultivation of Medicinal Plants
 
Quinolones.pptx
Quinolones.pptxQuinolones.pptx
Quinolones.pptx
 
Appetite stimulant and
Appetite stimulant   andAppetite stimulant   and
Appetite stimulant and
 
Pharmacognosy Families By AAA Arslan, Ayyaz, Asad
Pharmacognosy Families By AAA Arslan, Ayyaz, AsadPharmacognosy Families By AAA Arslan, Ayyaz, Asad
Pharmacognosy Families By AAA Arslan, Ayyaz, Asad
 
Respiratory stimulants
Respiratory stimulants Respiratory stimulants
Respiratory stimulants
 
Absorption of drugs
Absorption of drugs Absorption of drugs
Absorption of drugs
 
Herb drug & herb-food interactions
Herb drug & herb-food interactionsHerb drug & herb-food interactions
Herb drug & herb-food interactions
 
Herbs as raw materials
Herbs as raw materialsHerbs as raw materials
Herbs as raw materials
 
Herbal drug industry (unit 5)
Herbal drug industry (unit 5)Herbal drug industry (unit 5)
Herbal drug industry (unit 5)
 
4.3 thyroid hormones analogues and their inhibitors
4.3 thyroid hormones  analogues and their inhibitors4.3 thyroid hormones  analogues and their inhibitors
4.3 thyroid hormones analogues and their inhibitors
 
drug interaction
drug interactiondrug interaction
drug interaction
 
Biotransformation-pharmacology
Biotransformation-pharmacologyBiotransformation-pharmacology
Biotransformation-pharmacology
 

Similar to MedChem3_Part1_2022_Updated.pdf

Anti- microbial (Pharmacology)
Anti- microbial (Pharmacology)Anti- microbial (Pharmacology)
Anti- microbial (Pharmacology)
gaurav gautam
 
Sulfonamides,CO-TRIMOXAZOLE,QUINOLONES
Sulfonamides,CO-TRIMOXAZOLE,QUINOLONESSulfonamides,CO-TRIMOXAZOLE,QUINOLONES
Sulfonamides,CO-TRIMOXAZOLE,QUINOLONES
Dr.Arka Mondal
 
CHEMOTHERAPY OF TUBERCULOSIS AND LEPROSY.POWERPOINT.pptx
CHEMOTHERAPY OF TUBERCULOSIS AND LEPROSY.POWERPOINT.pptxCHEMOTHERAPY OF TUBERCULOSIS AND LEPROSY.POWERPOINT.pptx
CHEMOTHERAPY OF TUBERCULOSIS AND LEPROSY.POWERPOINT.pptx
SamuelAgboola11
 
Sulfonamides , Co-trimoxazole , urinary anti septic
Sulfonamides , Co-trimoxazole , urinary anti septicSulfonamides , Co-trimoxazole , urinary anti septic
Sulfonamides , Co-trimoxazole , urinary anti septic
JeenaJoy10
 
SULPHONAMIDES and Fluoroquinolones.pptx
SULPHONAMIDES and Fluoroquinolones.pptxSULPHONAMIDES and Fluoroquinolones.pptx
SULPHONAMIDES and Fluoroquinolones.pptx
sapnabohra2
 
Classes of Antibiotics, Therapeutic uses and their Side effects
Classes of Antibiotics, Therapeutic uses and their Side effectsClasses of Antibiotics, Therapeutic uses and their Side effects
Classes of Antibiotics, Therapeutic uses and their Side effects
achyuth kumar gurram
 
Antiulcer converted
Antiulcer convertedAntiulcer converted
Antiulcer converted
ankit sharma
 
Fluroquinolones 01 01-19
Fluroquinolones 01 01-19Fluroquinolones 01 01-19
Fluroquinolones 01 01-19
uma advani
 
Anti-Fungal drugs.pptx
Anti-Fungal drugs.pptxAnti-Fungal drugs.pptx
Anti-Fungal drugs.pptx
VikramSharma288
 
Quinolones and Fluoroquinolone MOA,ADME,Spectrum of activity of Quinolones.
Quinolones and Fluoroquinolone MOA,ADME,Spectrum of activity of Quinolones.Quinolones and Fluoroquinolone MOA,ADME,Spectrum of activity of Quinolones.
Quinolones and Fluoroquinolone MOA,ADME,Spectrum of activity of Quinolones.
FahimAnwarRizwi
 
Sulphonamides, Medicinal Chemistry-III,
Sulphonamides,  Medicinal Chemistry-III,Sulphonamides,  Medicinal Chemistry-III,
Sulphonamides, Medicinal Chemistry-III,
akhileshtiwari95
 
Sukh
SukhSukh
Sukh
iqb27
 
fluoroquinolones
fluoroquinolonesfluoroquinolones
fluoroquinolones
SalmanKhan1563
 
ANTI-TB AND ANTI LEPROTIC DRUGS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR.
ANTI-TB AND ANTI LEPROTIC DRUGS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR.ANTI-TB AND ANTI LEPROTIC DRUGS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR.
ANTI-TB AND ANTI LEPROTIC DRUGS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR.
Dr. Ravi Sankar
 
Sulphonamide and cotrimoxazole pptx-Dr.Jibachha Sah
 Sulphonamide and cotrimoxazole pptx-Dr.Jibachha Sah Sulphonamide and cotrimoxazole pptx-Dr.Jibachha Sah
Sulphonamide and cotrimoxazole pptx-Dr.Jibachha Sah
Dr. Jibachha Sah
 
Quinolone resistance
Quinolone resistanceQuinolone resistance
Quinolone resistance
SheemaKhanam
 
Resistance of quinolone
Resistance of quinoloneResistance of quinolone
Resistance of quinolone
SheemaKhanam
 
Sulfonamides and trimethoprim
Sulfonamides and trimethoprimSulfonamides and trimethoprim
Sulfonamides and trimethoprim
Subramani Parasuraman
 
B. Pharm Graduate Medicinal Chemistry Unit III Quinolones, Fluoroquinolones &...
B. Pharm Graduate Medicinal Chemistry Unit III Quinolones, Fluoroquinolones &...B. Pharm Graduate Medicinal Chemistry Unit III Quinolones, Fluoroquinolones &...
B. Pharm Graduate Medicinal Chemistry Unit III Quinolones, Fluoroquinolones &...
Prof. Aejaz Ahmed Boraji
 
Sulphonamides and Quinolones
Sulphonamides and QuinolonesSulphonamides and Quinolones
Sulphonamides and Quinolones
BikashAdhikari26
 

Similar to MedChem3_Part1_2022_Updated.pdf (20)

Anti- microbial (Pharmacology)
Anti- microbial (Pharmacology)Anti- microbial (Pharmacology)
Anti- microbial (Pharmacology)
 
Sulfonamides,CO-TRIMOXAZOLE,QUINOLONES
Sulfonamides,CO-TRIMOXAZOLE,QUINOLONESSulfonamides,CO-TRIMOXAZOLE,QUINOLONES
Sulfonamides,CO-TRIMOXAZOLE,QUINOLONES
 
CHEMOTHERAPY OF TUBERCULOSIS AND LEPROSY.POWERPOINT.pptx
CHEMOTHERAPY OF TUBERCULOSIS AND LEPROSY.POWERPOINT.pptxCHEMOTHERAPY OF TUBERCULOSIS AND LEPROSY.POWERPOINT.pptx
CHEMOTHERAPY OF TUBERCULOSIS AND LEPROSY.POWERPOINT.pptx
 
Sulfonamides , Co-trimoxazole , urinary anti septic
Sulfonamides , Co-trimoxazole , urinary anti septicSulfonamides , Co-trimoxazole , urinary anti septic
Sulfonamides , Co-trimoxazole , urinary anti septic
 
SULPHONAMIDES and Fluoroquinolones.pptx
SULPHONAMIDES and Fluoroquinolones.pptxSULPHONAMIDES and Fluoroquinolones.pptx
SULPHONAMIDES and Fluoroquinolones.pptx
 
Classes of Antibiotics, Therapeutic uses and their Side effects
Classes of Antibiotics, Therapeutic uses and their Side effectsClasses of Antibiotics, Therapeutic uses and their Side effects
Classes of Antibiotics, Therapeutic uses and their Side effects
 
Antiulcer converted
Antiulcer convertedAntiulcer converted
Antiulcer converted
 
Fluroquinolones 01 01-19
Fluroquinolones 01 01-19Fluroquinolones 01 01-19
Fluroquinolones 01 01-19
 
Anti-Fungal drugs.pptx
Anti-Fungal drugs.pptxAnti-Fungal drugs.pptx
Anti-Fungal drugs.pptx
 
Quinolones and Fluoroquinolone MOA,ADME,Spectrum of activity of Quinolones.
Quinolones and Fluoroquinolone MOA,ADME,Spectrum of activity of Quinolones.Quinolones and Fluoroquinolone MOA,ADME,Spectrum of activity of Quinolones.
Quinolones and Fluoroquinolone MOA,ADME,Spectrum of activity of Quinolones.
 
Sulphonamides, Medicinal Chemistry-III,
Sulphonamides,  Medicinal Chemistry-III,Sulphonamides,  Medicinal Chemistry-III,
Sulphonamides, Medicinal Chemistry-III,
 
Sukh
SukhSukh
Sukh
 
fluoroquinolones
fluoroquinolonesfluoroquinolones
fluoroquinolones
 
ANTI-TB AND ANTI LEPROTIC DRUGS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR.
ANTI-TB AND ANTI LEPROTIC DRUGS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR.ANTI-TB AND ANTI LEPROTIC DRUGS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR.
ANTI-TB AND ANTI LEPROTIC DRUGS [MEDICINAL CHEMISTRY] BY P.RAVISANKAR.
 
Sulphonamide and cotrimoxazole pptx-Dr.Jibachha Sah
 Sulphonamide and cotrimoxazole pptx-Dr.Jibachha Sah Sulphonamide and cotrimoxazole pptx-Dr.Jibachha Sah
Sulphonamide and cotrimoxazole pptx-Dr.Jibachha Sah
 
Quinolone resistance
Quinolone resistanceQuinolone resistance
Quinolone resistance
 
Resistance of quinolone
Resistance of quinoloneResistance of quinolone
Resistance of quinolone
 
Sulfonamides and trimethoprim
Sulfonamides and trimethoprimSulfonamides and trimethoprim
Sulfonamides and trimethoprim
 
B. Pharm Graduate Medicinal Chemistry Unit III Quinolones, Fluoroquinolones &...
B. Pharm Graduate Medicinal Chemistry Unit III Quinolones, Fluoroquinolones &...B. Pharm Graduate Medicinal Chemistry Unit III Quinolones, Fluoroquinolones &...
B. Pharm Graduate Medicinal Chemistry Unit III Quinolones, Fluoroquinolones &...
 
Sulphonamides and Quinolones
Sulphonamides and QuinolonesSulphonamides and Quinolones
Sulphonamides and Quinolones
 

Recently uploaded

CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
DRPREETHIJAMESP
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
walterHu5
 

Recently uploaded (20)

CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHYMERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
MERCURY GROUP.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxDoes Over-Masturbation Contribute to Chronic Prostatitis.pptx
Does Over-Masturbation Contribute to Chronic Prostatitis.pptx
 

MedChem3_Part1_2022_Updated.pdf

  • 1. Al-Zaytoonah University of Jordan Faculty of Pharmacy Medicinal Chemistry 3 Course #: 0201414 3 Credit Hours Part 1 Rima Hajjo, MS, PhD rima.hajjo@zuj.edu.jo
  • 2. Course Outline 1) Antibacterial/Antimicrobial Agents 2) Antibiotics 3) Antimycobacterial agents 4) Antifungal agents 5) Anti-parasites 6) Antiviral agents 7) Anticancer agents
  • 3. Al-Zaytoonah University of Jordan Faculty of Pharmacy MedChem 3 Course #: 3 Credit Hours Antimicrobial/Antibacterial Agents Ø Sulfonamides Ø Quinolones Ø Nitrofurans Ø Methenamine Ø Fosmycin Ø Metronidazole
  • 5. Introduction: Mechanisms of Antibacterial Agents Madigan and Martinko, 2006 Fostomycin
  • 6. (1) SULFONAMIDES ØSynthetic Antibacterial Agents ØUsed Mainly for Urinary Tract Infections (UTIs) ØGeneral Considerations: • First, Sulfonamides came into use in the mid 1930’s • Then Penicillins in the 40’s • Combination therapies in the 1970’s (Co-trimoxazole) • FLuoroquinolones in the 1990’s ØTherapeutic Indications: • Lower UTI’s – urethritis, cystitis, prostatitis • Upper UTI’s – Pyelonephritis
  • 7. The Discovery of Sulfonamides Antibacterial Agents Prontosil rubrum and patented as Prontosil, is an azo dye, introduced in 1935 by Gerhard Domagk, Bayer, Germany. Inactive in vitro! Active in vivo. Natural Bacterial Metabolite Antimetabolite PABA p-aminobenzenesulfonic acid amide Azo bond confers prodrug qualities “Azo compound” The first drug to successfully treat bacterial infections and the first of many sulfa drugs— forerunners of antibiotics. This achievement earned its creator a Nobel Prize. reductive cleavage of the azo bond
  • 8. Mechanism of Action: Sulfonmaides Inhibit Microbial Biosynthetic Pathway of Tetrahydrofolic Acid Synthesis Glutamic acid 6-hydroxymethyl-7,8-dihydropterin-pyrophosphate The basis of selective toxicity to bacteria is clear! Bacteria need to synthesize THFA in vivo, while humans rely on food and supplements for folic acid and don’t synthesize it in vivo. Sulfonamides are bacteriostatic ‘THFA’ THFA is required for DNA synthesis
  • 9. Structure Activity Relationships (SAR) of Sulfonamides SAR: 1. N4 must be unsubstitued or capable of regeneration of NH2 2. No substitution on the aromatic ring 3. Acidic proton on N1 S H2N O O N H H C H2N O O H pKa = 6.5 pKa = 10.4 Acidic Ar = pKa N O H3C CH3 5.0 MIC 2.15 H 10.4 128.0 O N CH3 6.0 0.8 N N 6.52 0.9 N N S 5.5 --- CH3 S H2N O O N H Ar 4. Exchange SO2NHR by CONHR reduces the activity (because of decreased acidity of N1 proton) 5. The amine and sulphonamide groups have to be para to each other PABA Sulfanilamide N4 N1 Thiadiazole Pyrimidine Isoxazole Isoxazole
  • 10. Pharmacokinetics of Sulfonamides S H2N O O N H Ar S NH O O N H Ar C O H3C N4 acetylation (aniline nitrogen) “Inactive” 1) Metabolism S H2N O O N Ar Salt 2) Salt formation “Acidic proton allows salt formation” Acidic proton Sodium Salts are very alkaline because Na+ is quite alkaline (more irritation) causing crystalurea N OH OH H H Diethanolamine is close to neutral and its sulfonamide salts are nearly neutral (i.e., less irritation) Site of acetylation “less painful/less irritation for eyes” Diethanolamine Irritation Two problems: 1) Inactivated by metabolism and 2) low water solubility
  • 11.
  • 12. Pharmacokinetics 1) Most sulfonamides are well absorbed orally and they are widely distributed including to the CNS. 2) The concentrations in the kidney are the highest. So they are suitable for treating urinary tract infections. 3) Lower solubility in the urine, most sulfonamides and their metabolites easily cause crystalluria, bloody urine, and kidney damage.
  • 13. According to administration route and the degree of absorption in intestinal tract, can be divided into: ①Oral, absorbable: well absorbed in intestinal tract and mainly used to treat general infections. On the basis of their half-lives, also be classified as short-, medium-, or long-acting ones such as sulfisoxazole, sulfamethoxazole and sulfadoxine; ②Oral, nonabsorbable: poorly absorbed in intestinal tract and mainly used to treat intestinal tract infections; such as sulfasalazine. ③Topical: such as SD-Ag and sulfamylone. Clinical Uses and “Classification of Sulfonamides”
  • 14. Orally Absorbable S O O H N O N H2N S O O NH H2N N N Sulfamethoxazole Sulfadiazine Sulfisoxazole Sulfadoxine Sulfamethizole
  • 15. Mafenide/Sulfamylone (Burns) Topical S O O NH H2N O Sulfacetamide (Eye drops) Silver sulfadiazine (Wounds, Burns) Sulfasalazine (intestinal infections) Orally Nonabsorbable mafenide acetate
  • 16. Resistance to Sulfonamides ØUsually occurs by increasing the PABA concentration or a change in the enzyme structure to better distinguish between PABA and the drug. ØSome bacteria are intrinsically resistant since they can uptake Folic acid from their surroundings. ØThe use of sulfamethoxazole and other sulfonamides has been limited by the increasing incidence of resistant organisms. Their main use has been in the treatment of acute, uncomplicated urinary-tract infections, particularly those caused by Escherichia coli.
  • 17. Combination Therapy for UTIs: Sulfonamide + Trimethoprim N N N N O H2N H H O P O O OH P O OH OH H2N CO2H PABA + N N N N O H2N N CO2H H H H Dihydropteroic Acid Glutamic acid N N N N O H2N N C N CO2H CO2H Dihydrofolic Acid H H H o H Dihydrofolate reductase N N N N O H2N N C N H CO2H CO2H Tetrahydrofolic Acid H H H H O S H2N O O N H H Dihydropteroate diphosphate Trimethoprim Dihydropteroate Synthase Sulfonamide
  • 18. Trimethoprim Site of action of trimethoprim Antimetabolite
  • 19.
  • 20. Al-Zaytoonah University of Jordan Faculty of Pharmacy MedChem 3 3 Credit Hours Rima Hajjo, MS, PhD rima.hajjo@zuj.edu.jo (2) Quinolone/Fluoroquinolone Antibacterial Agents
  • 21. Quinolones: Background Ø Broad spectrum antibacterial. Ø The first discovered quinolone antibacterial for clinical use was Nalidixic acid (not in clinical use anymore because safer quinolones were discovered). Ø Now, nearly all quinolone drugs in clinical use are fluoroquinolones. Ø We developed/used as antibacterial agents in the 60s. Nalidixic acid Ø Due to increased concerns about toxicities and side effects, the FDA issued black box warnings in 2008, 2016, 2018. Example on black box warning for other drugs
  • 22. General Structure and Pharmacophore 1 2 3 4 5 6 7 8 Spectrum of activity Atom number 8 used to be N, then changed to C to reduce side effects. Most quinolone drugs in clinical use have C at position 8.
  • 23. Mechanism of action of Quinolones ØQuinolones inhibit bacterial topoisomerase enzymes, resulting in inhibition of replication and transcription. ØInhibition of DNA gyrase in G- (also called topoisomerase II in G-) and topoisomerase IV in G+, which are key bacterial enzymes that dictate the conformation of DNA à that’s why the quinolones are rapidly bactericidal.
  • 24. ØNalidixic acid was the first quinolone introduced to clinic in 1962 to fight against Gram negative urinary tract infections (UTIs) à it is considered a first- generation quinolone based on its spectrum of activity and pharmacokinetic properties. It is discontinued. ØFirst-generation agents are limited to uncomplicated urinary tract infections. And they have problems with toxicity, antibacterial spectrum, and metabolism. 1 2 3 4 First Generation Quinolones
  • 25. Second Generation Quinolones Broader spectrum against Gram Negative Longer half life Less protein binding when X = CH
  • 26. Third Generation Quinolones The third-generation quinolones include levofloxacin, gatifloxacin, and gemifloxacin. It is 4th generation in some references
  • 27. Fourth Generation Quinolones The first chlorinated fluoroquinolone developed. Trovafloxacin Removed from clinical use in 1999 Hepatotoxic
  • 28. Summary Generation Agents Antimicrobial Spectrum Properties First Nalidixic acid Cinoxacin Gram negative (not Pseudomonas) Poor serum and tissue concentration. Not for systemic infections Second Norfloxacin Lomefloxacin Enoxacin Ofloxacin Ciporfloxacin Gram negative (including Pseudomonas), Some Gram positive Adequate serum and tissue concentrations. Good for systemic infections. Third Levofloxacin Sparfloxacin Gatifloxacin Moxifloxacin Same as for second- gen. generation plus expanded Gram positive Once-daily dosing Fourth Trovafloxacin Besifloxacin Same as for third- gen. plus broad anaerobic coverage Active against anaerobic Gram- positive and negative
  • 29. General Structure and SAR Ring 1 Ring 2
  • 30. SAR of Quinolones: Rings N O R COOH N O R COOH 1 2 3 4 5 6 1 2 3 4 5 6 7 8 Substituted 1,4-dihydro-4-oxo- 3-pyridinecarboxylic acid Substituted quinolone 3-carboxylic acid Ø1,4-dihydro-4-oxo-3-pyridinecarboxylic acid portion is necessary for the antibacterial activity. ØThe pyridone ring (ring 1) must be attached to an aromatic ring (ring 2), in which isosteric substitution of carbon with nitrogen maintains the activity. Ring 1 Ring 2
  • 31. SAR: Isosteric substitutions on ring 2 ØIsosteric substitution of carbon with nitrogen maintains the antibacterial activity. N N O R COOH 1 2 3 4 5 6 7 8 N N O R COOH 1 2 3 4 5 6 7 8 N N O R COOH 1 2 3 4 5 6 7 8 N N O R COOH 1 2 3 4 5 6 7 8 Cinnolines 1,5-Naphthyridines 1,6-Naphthyridines 1,8-Naphthyridines Ring 1 Ring 2
  • 32. SAR: N1 alkyl substitutions ØN1-Substitution is necessary for the antibacterial activity. Small alkyl or cycloalkyl groups increase the antibacterial activity in the following order: cyclopropyl >ethyl >methyl. N O COOH 1 2 3 4 5 8 N HN F 7 6 N O COOH 1 2 3 4 5 8 CH3 N HN F 7 6 Ciprofloxacin Norfloxacin
  • 33. SAR: N1 aryl substitutions ØN1- Aryl substitution maintains the activity and sometimes optimises it. N O COOH 1 2 3 4 5 N F 7 6 H2N F 8 F F Trovafloxacin
  • 34. SAR: Substitutions on C2, C5, C6, C7 & C8 N O R COOH 1 2 3 4 5 6 7 8 ØSubstitution at C2 position decreases the activity remarkably or changes the antibacterial characters. ØSubstitution at C5 , C6 , C7 and at C8 has good effects on the activity. ØC6 fluorine substitution increases the activity prominently, That’s why quinolones are also called fluoroquinolones. ØSubstituted or unsubstituted piperazinyl or pyrrolidinyl groups at C7 increase the activity against P. aeroginosa (spectrum of activity) Sparfloxacin
  • 35. SAR: New ring (ring fusion) from N1 to C8 N O COOH 1 2 3 4 5 N H3CN F 7 6 O CH3 H 8 Ofloxacin Levofloxacin (-)S N X O CH3 COOH O O X: N = Cinoxacin X: CH = Oxolinic acid 1 3 4 5 7 8 2 6 ØRing fusion at N1and C8; C5 and C6; C6 and C7 or C7 and C8 introduces active compounds: Examples:
  • 36. N N N O CO2H F F F H H N H O NH H3C H O H3C NH2 Alatrofloxacin Prodrug N N N O CO2H F F F H H H2N Trovafloxacin SAR: Amino Acid Substitutions Alanines in alatrofloxacin are introduced to improve drug transportation into cell/improve absorption. Removed from clinical use in 1999 Hepatotoxic
  • 37. SAR of Toxicity and Side Effects Can J Infect Dis. 2002 Jan;13(1):54-61. Associated with CytP450 interactions
  • 38. SAR Consideration: Metal Chelation Ø The ability of these drugs to chelate polyvalent metal ions (Ca2+ , Mg2+ , Zn2+ , Fe2+, Al3+ ), resulting in decreased solubility and reduced drug absorption. Ø Causes kidney caliculi and crystalluria. (advice patients to drink lots of water) Ø Chelation occurs between the metal and the 3-carboxylic acid and 4-keto groups. Ø Agents containing polyvalent metals should be administered separately from the quinolones. Molecules. 2013 Sep; 18(9): 11153–11197. A problem of chemical incompatibility of all Quinolones Metal chelate
  • 39. SAR of Toxicity: CNS toxicity ØUnlike many anti-infective drugs, the quinolones can cause severe CNS effects even after short-term use. ØCNS side effects include: Tremor, sleep disorders, anxiety, and convulsions because they cause GABA antagonism at the receptor. ØBecause of low penetration to brain this toxicity is rare. Flumequine (first generation) Causes severe CNS side effects
  • 40. Important Structural Modifications Ø The most active of the fluoroquinolones against Gram-negative bacteria. Ø A cyclopropyl substituent at position 1 further increased spectrum of activity. Ø Replacement of the nitrogen at position 8 with carbon reduced adverse reactions and increased activity against S. aureus. ØQuinolones were of little clinical significance until the addition of a fluoro group to C6 greatly increased the biologic activity à it improved cell wall penetration. ØA piperazinyl ring at position 7, was also beneficial for a variety of pharmacokinetic reasons due to the ability of the basic substituent to form a zwitterion with the carboxylic acid group at position 3. This property appears to radically enhance the ability of these compounds to penetrate the outer membrane of Gram negative bacteria.
  • 41. Critical for binding Improves activity against a variety of organisms (Spectrum of activity) O COOH HO OH OH O C O N O R1 F R Phase 2 Conjugation Phase 1 CYP 450 (1A2) N O COOH R1 N N F R2 HO Potency Pharmacophore F N N O R1 O OH Cell penetration Gyrase inhibition Metabolism of Quinolones Inactive Reduced activity
  • 42. Al-Zaytoonah University of Jordan Faculty of Pharmacy MedChem 3 Course #: 0201511 3 Credit Hours Rima Hajjo, MS, PhD r.hajjo@zuj.edu.jo (3) Nitrofurans and Other Antimicrobial Agents
  • 43. Ø Widely used oral antibacterial since WWII. It is used for prophylaxis or treatment of acute urinary tract infections when kidney function is NOT impaired. Ø Nausea and vomiting are common. Severe side effects can be experienced when using this drug (acute pulmonary reactions, peripheral neuropathy, hemolytic anemia, liver toxicity, and fertility impairment). Ø Inhibits DNA and RNA functions through mechanisms that are not well understood. There is little acquired resistance. Nitroheteroaromatic compounds: Ø Used orally for the treatment of trichomoniasis, giardiasis, and Gardnerella vaginalis infections. It has found increasing use of late in the parenteral treatment of anaerobic infections and for treatment of pseudomembranous colitis due to Clostridium difficile (opportunistic pathogen that occasionally flourishes as a consequence of broad-spectrum antibiotic therapy, and infections can be life- threatening). Important Antiparasitic agent. Ø It is believed to be metabolically activated by reduction of its nitro group to produce metabolites that interfere with DNA and RNA function. 1) 2)
  • 44. O C H O2N N N O O Furazolidone O C H O2N N N NH O O Nitrofurantoin O C H N N N NH O O H HO Metabolism Active form O C H N N N NH O O H H Extended conjugation of electrons (Brown Color à urine discoloration) Nitrofurans For UTIs O C H O2N X For the management of chronic prostatitis. Can cause hepatic injury (Hepatic drug reactions are more common in females for unknown reasons). Other examples: acetaminophen, halothane, nitrofurantoin, diclofenac, and sulindac. More on nitrofurans
  • 45. Synthesis of Nitrofurantoin Ø Replacing the furan ring with other five-membered rings such as thiophene and pyrrole are less active). Ø Replacing nitro with other isolelectric groups (e.g., sulfo, sulfamoyl, carboxyl or cyano) reduce the antibacterial activity. SAR: thiophene pyrrole furan O C H O2N X O O2N R S O2N R NH O2N R
  • 46. Protein N C H H Methenamine (Hexamethylenetetramine) For UTIs Can form Schiff base with protein (Hexamine) Acidic media Schiff base (imine)
  • 47. Fosfomycin Ø Fosfomycin (also known as phosphomycin) inhibits enolpyruvial transferase, an enzyme catalyzing an early step in bacterial cell wall biosynthesis. Inhibition results in reduced synthesis of peptidoglycan, an important component in the bacterial cell wall. Ø Fosfomycin is bactericidal against Escherichia coli and Enterobacter faecalis infections. Ø It is used for treatment of uncomplicated urinary tract infections by susceptible organisms. For UTIs
  • 48. Phenazopyridine N N H2 NH2 N N UTI Analgesic (does not have antibacterial properties) Azo dye bright red in color Urinary analgesic – does not heal infections For UTIs
  • 49. Al-Zaytoonah University of Jordan Faculty of Pharmacy MedChem 3 Course #: 0201511 3 Credit Hours Rima Hajjo, MS, PhD r.hajjo@zuj.edu.jo β-Lactam Antibiotics - Penicillins
  • 50. Agenda Penicillins What we need to know? ① Pharmacophore structure ② General Structures (highlighted in lecture) ③ SAR ④ How to improve: in vitro stability, administration route (oral is better), stability towards β –lactamases, spectrum of activity (antibacterial activity) ⑤ Important Mechanisms of action, or reaction mechanisms.
  • 51. Introduction: Antibiotics What is an antibiotic? 1) It is a product of metabolism. 2) It is a synthetic product produced as structural analogue of naturally occurring antibiotic. 3) It antagonizes the growth or survival of one or more species of microorganisms. 4) It is effective in low concentrations. Modes of action: 1) Cell wall synthesis inhibitors 2) Cell membrane inhibitors 3) Protein synthesis inhibitors 4) Nucleic acids synthesis inhibitors Major antibiotic classes that inhibit bacterial cell wall biosynthesis are: 1) β – Lactam antibiotics which include penicillins , cephalosporins and carbapenems. 2) Monobactams. 3) Polypeptides.
  • 52. Introduction: β – Lactam Antibiotics ØAntibiotics that possess the β – Lactam ring (a four-membered cyclic amide) such as penicillins and cephalosporins. ØThis group of antibiotics have: 1)Broad spectrum of antibacterial action 2)Potent and rapid bactericidal action against bacteria in the growth phase. 3)Low frequency of toxic and other side effects in host.
  • 53. Ring Types and Numberings of Clinically Available Βeta-lactam Antibiotics Memorize these!
  • 54. The First β-Lactam Antibiotics: Penicillins Ø Penicillins are the most widely used antibioticsin the World. Ø Penicillins are antibacterial agents which inhibit bacterial cell wall synthesis Discovered by Fleming from a fungal colony (1928) shown to be non toxic and antibacterial. First used on humans in 1942 (US, Streptococcal septicemia). Ø The original fermentation-derived penicillins were produced by growth of the fungus Penicillium chrysogenum. Penicillin G Fermentation-derived Active against G+ mainly
  • 55. Biosynthesis of Penicillin Two prototypes: Memorize this structure for 6-APA in the blue box. Benzyl penicillin: (2S,5R,6R)-3,3-Dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane- 2-carboxylic acid. à IUPAC 1 2 3 4 5 7
  • 56. Semisynthetic Penicillins Then 6-APA is used to synthesize other “improved” penicillins 6-aminopenicillanic acid (6-APA) is synthesized by hydrolyzing naturally produced Penicillin G. Then 6-APA is used to synthesize other penicillins (semisynthetic because it relied on a naturally-occurring precursor). Synthesis of 6-APA from penicillin G
  • 57. The 3D Shape of Penicillin Ø Penicillin contains a highly unstable bicyclic system consisting of a four-membered β –lactam ring fused to a five- membered thiazolidine ring. Ø The skeleton of the molecule suggests that it is derived from the amino acids cysteine and valine, and this has been established. Ø The overall shape of the molecule is like a half-open book, as shown on the left.
  • 58. Peptidoglycan Structure of Bacterial Cell Walls is the Target for Penicillins Ø β – Lactams bind at the active site of the transpeptidase enzyme that cross-links the peptidoglycan strands at the positions indicated by arrows on the figure above. Ø It does this by mimicking the D-alanyl-D-alanine residues that would normally bind to this site.
  • 59. Mechanism of Action of Penicillins The enzyme responsible for the cross- linking reaction is known as the transpeptidase enzyme . Ø β – Lactams including penicillin irreversibly inhibit the enzyme transpeptidase by reacting with a serine residue in the transpeptidase à inhibit cell wall synthesis. Ø Cell walls are essential for bacteria to live. Ø Cross-linking of bacterial cell walls inhibited by penicillin
  • 60. Penicillin Mimics the Natural Substrate Figure. Comparison of penicillin, 6-substituted penicillins, and acyl-d-Ala-d-Ala.
  • 61. Mechanism of Transpeptidase Cross-linking and Inhibition by Penicillins
  • 62. β-Lactam Ring Acting as an Acylating Agent
  • 63. Penicillin as a an Inhibitor for β-Lactamases
  • 65.
  • 66. Penicillins: Structure Activity Relationships (SAR) Agenda: ØSAR Considerations ØStructural Modifications ØProdrugs ØDrugs that synergize with penicillins
  • 67. Major SAR Considerations, Chemical and Biological Instabilities 1) Hydrolysis by beta-lactamases (penicllinases in case of penicillins) 2) Instability in basic media or in presence of nucleophiles (e.g., OH-) 3) Instability in acids
  • 68. 1) Deactivation by Beta-lactamases Mechanism of β-lactamase Deactivation of Penicillin: You need to know this!
  • 69. How to Reduce Sensitivity (increase resistance) to Beta-lactamases? Fig. β-Lactamase resistant/sensitive structural features.
  • 70. 2) Instability of Βeta-lactams to Nucleophiles Hydrolysis in basic media
  • 71. 3) Instability of Penicillins in Acid Hydrolysis involves the C-6 side chain. Hydrolysis in Acidic media Skip Mechanism just remember how it is related to the the C-6 side chain.
  • 72. Ring Opening of Penicillins Leads to Loss of Antibiotic Activity
  • 73. Comparison of Tertiary Amide and β- Lactam Carbonyl Groups
  • 74. Structural Modifications to Solve the Main Problems of Penicillins: 1) Oral Bioavailability 2) Deactivation by beta-lactamases 3) Spectrum of activity 4) PK properties/Prodrugs SAR Rules
  • 75. Making Penicillins Orally Active (i.e., resistant to acidic hydrolysis)
  • 76. How Improve Acid Stability to Allow Oral Administration 1) Pen V 2) Amino Penicillins
  • 78. Orally Active, Acid and β-Lactamase Resistant
  • 79. Broad Spectrum Penicillins 1) Aminopenicillins 2) Carboxypenicillins
  • 80. Hydrophilic Groups on the Side Chains of R on the 6th Position of the lactam Ring Hydrophilic groups on the side chain have little effect on Gram-positive activity (e.g. penicillin T) or cause a reduction of activity (e.g. penicillin N). However, they lead to an increase in activity against Gram-negative bacteria
  • 81. Prodrugs to Aid Absorption of Ampicillin Through the Gut Wall Mechanism of hydrolysis of prodrugs:
  • 82. Polar Extended Ester for Penicillin G
  • 83. Broad-spectrum Penicillins: Ureidopenicillins Ø Ureidopenicillins (Figure above) are the newest class of broad-spectrum penicillins and have a urea functional group at the α-position. Ø Generally, they have better properties than the carboxypenicillins and have largely replaced them in the clinic.
  • 84. Synergism of Penicillins with Beta Lactamse Inhibitors Clavulanic Acid
  • 85. Synergism of Penicillins with Probencid Probencid Ø Probenecid is a moderately lipophilic carboxylic acid that can block facilitated transport of penicillin through the kidney tubules and slows down the rate at which penicillin is excreted. Ø Probenecid also competes with penicillin for binding sites on albumin. As a result, penicillin levels in the bloodstream are enhanced and the antibacterial activity increases—a useful tactic if faced with a particularly resistant bacterium.
  • 86. Key Points: Penicillins ① Penicillins have a bicyclic structure consisting of a β-lactam ring fused to a thiazolidine ring. ② The strained β-lactam ring reacts irreversibly with the transpeptidase enzyme responsible for the final cross-linking of the bacterial cell wall. ③ Penicillin analogues can be prepared by fermentation or by a semi-synthetic synthesis from 6-aminopenicillanic acid. ④ Variation of the penicillin structure is limited to the acylside chain or -OMe on 6th position carbon of the beta lactam ring. ⑤ Penicillins can be made more resistant to acid conditions by incorporating an electron-withdrawing group into the acyl side chain. ⑥ Steric shields can be added to penicillins to protect them from bacterial β-lactamase enzymes. ⑦ Broad spectrum activity is associated with the presence of an α-hydrophilic group on the acyl side chain of penicillin. ⑧ Prodrugs of penicillins are useful in masking polar groups and improving absorption from the gastrointestinal tract. ⑨ Extended esters are used which undergo enzyme-catalysed hydrolysis to produce a product which degrades spontaneously to release the penicillin. ⑩ Probenecid can be administered with penicillins to hinder the excretion of penicillins.
  • 87. Al-Zaytoonah University of Jordan Faculty of Pharmacy MedChem 3 Course #: 0201511 3 Credit Hours Rima Hajjo, MS, PhD r.hajjo@zuj.edu.jo β-Lactam Antibiotics - Cephalosporins
  • 88. Agenda ØCephalosporins What we need to know? ① Pharmacophore structure ② General Structures (highlighted in lecture) ③ SAR ④ How to improve: in vitro stability, administration route (oral is better), stability towards β –lactamases, spectrum of activity (antibacterial activity) ⑤ Important Mechanisms of action, or reaction mechanisms.
  • 89. Cephalosporin C Amino Adipic Acid IUPAC NAME: (6R,7R)-3-[(Acetyloxy)methyl]-7-{[(5R)-5- amino-5-carboxypentanoyl]amino}-8-oxo-5- thia-1-azabicyclo[4.2.0]oct-2-ene-2- carboxylic acid 1 2 3 4 5 6 7 8
  • 90. Mechanism of Inhibition of Transpeptidase by Cephalosporins
  • 92. Positions for Possible Modification of Cephalosporin C. The shading indicates positions which can be varied 2 3 1 4 5 6 8
  • 93. First Generation Cephalosporins thiophene Acetyloxy group at position 3 is readily hydrolyzed by esterase enzymes to give the less active alcohol. Metabolic Hydrolysis of Cephalothin: Cephalothin
  • 94. First Generation Cephalosporins Ø Cephaloridine exists as a zwitterion and is soluble in water, but, like most first generation cephalosporins, it is poorly absorbed through the gut wall and has to be injected. Pyridinium at C3 in Cephaloridine is metabolically stable. The pyridine can still act as a good leaving group for the inhibition mechanism, but is not cleaved by esterases. Ø The Me at C3 in Cefalexin increases absorption through the gut and is stable to metabolism à orally bioavailable. Orally absorbed Cephaloridine Cefalexin
  • 95. Other First Generation Cephalosporins Modifications on two positions: R and X Cefazolin Cephalexin Cefadroxil Parenteral Oral
  • 96. Second Generation Cephalosporins: Cephamycins Ø Cephamycins contain a methoxy substituent at position 7, which has proved advantageous. Modification of the side chain gave cefoxitin, which showed a broader spectrum of activity than most first-generation cephalosporins. This is due to greater resistance to β–lactamase enzymes, which may be due to the steric hindrance provided by the methoxy group. Ø Cefoxitin showed good metabolic stability to esterases owing to the presence of the urethane group at position 3, rather than an ester. Urethrane group Urethrane group Cephamycin C Cefoxitin
  • 97. Second Generation: Oximinocephalosporins Ø Oximinocephalosporins has been a major advance in cephalosporin research. These structures contain an iminomethoxy group at the α –position of the acyl side chain, which significantly increases the stability of cephalosporins against the β -lactamases produced by some organisms (e.g. Haemophilus influenza ). Ø Increased resistance to β -lactamases and mammalian esterases (like cefoxitin). Unlike cefoxitin, cefuroxime retains activity against streptococci and, to a lesser extent, against staphylococci. Urethrane group
  • 98. Examples: Second Generation Modifications on 4 positions: R, X, Y and Z Parenteral Cefuroxime Cefotetan Cefoxitin Cefaclor Cefprozil Oral
  • 99. Third Generation Cephalosporins ØAminothiazolering in Ceftazidime enhances the penetration of cephalosporins through the outer membrane of Gram-negative bacteria, and may also increase affinity for the transpeptidase enzyme. As a result, third-generation cephalosporins containing this ring have a marked increase in activity against these bacteria.
  • 100. Third Generation Cephalosporins Ø Other 3rd generation compounds: cefotaxime, ceftizoxime, and ceftriaxone, with different substituents at position 3 to vary the pharmacokinetic properties. They play a major role in antimicrobial therapy because of their activity against Gram-negative bacteria, many of which are resistant to other β –lactams. Ø As such infections are uncommon outside hospitals, physicians are discouraged from prescribing these drugs routinely and they are viewed as ‘reserve troops’ to be used for troublesome infections which do not respond to the more commonly prescribed β - lactams. (R) Iminomethoxy Aminothiazole
  • 103. Fourth Generation Cephalosporins Ø They are zwitterionic compounds having a positively charged substituent at position 3 and a negatively charged carboxylate group at position 4. This property appears to radically enhance the ability of these compounds to penetrate the outer membrane of Gram negative bacteria. Ø They are also found to have a good affinity for the transpeptidase enzyme and a low affinity for a variety of β-lactamases. Iminomethoxy Aminothiazole
  • 104. Special Considerations for Oximes on the 7th position Ø Z-oxime is preferred over the E-oxime Ø Stability toward β-lactamase can be increased around 100-fold with the addition of methoxyoxime. Z-oxime is nearly 20,000-fold more stable than the E-oxime
  • 105. Prodrug Cephalosporins N S O H H HN O OCONH2 O NOCH3 O O O CH3 CH3 O N S O H HN O OCH3 NOCH3 H N S H2N O O CH3 O O O CH3 CH3 Cefuroxime axetil Cefpodoxime proxetil
  • 106. Another Prodrug: “Fifth-generation” Cephalosporin Has activity against various strains of MRSA and multi-resistant Streptococcus pneumonia (MDRSP). Ceftaroline fosamil Newest Cephalosporin The 1,3-thiazole ring is thought to be important for its activity against MRSA.
  • 107. Resistance to Cephalosporins Ø The activity of a specific cephalosporin against a particular bacterial cell is dependent on the same factors as those for penicillins. i.e. the ability to reach the transpeptidase enzyme, stability to any β -lactamases which might be present, and the affinity of the antibiotic for the target. Ø For example, most cephalosporins (with the exception of cephaloridine) are stable to the β -lactamase produced by S. aureus and can reach the transpeptidase enzyme without difficulty. Therefore, the relative ability of cephalosporins to inhibit S. aureus comes down to their affinity for the target transpeptidase enzyme. Agents such as the cephamycins and ceftazidime have poor affinity, whereas other cephalosporins have a higher affinity. Ø The MRSA organism contains a modified transpeptidase enzyme ( PBP2a) for which both penicillins and cephalosporins have poor affinity.
  • 108. Key Points: Cephalosporins Ø Cephalosporins contain a strained β-lactam ring fused to a dihydrothiazine ring. Ø In general, first-generation cephalosporins offer advantages over penicillins in that they have greater stability to acid conditions and β-lactamases, and have a good ratio of activity against Gram-positive and Gram-negative bacteria. However, they have poor oral availability and are generally lower in activity. Mainly reserved for parenteral formulations. Ø Variation of the 7-acylamino side chain alters antimicrobial activity, whereas variation of the side chain at position 3 predominantly alters the metabolic and pharmacokinetic properties of the compound. Introduction of a methoxy substitution at C-7 is possible, making compounds more resistant to beta lactamases. Ø Semisynthetic cephalosporins can be prepared from 7-aminocephalosporanic acid (7-ACA). 7-ACA is obtained from the chemical hydrolysis of natural cephalosporins.
  • 109. Key Points: Cephalosporins Ø Deacetylation of acetyl groups on 3rd position of cephalosporins occurs metabolically to produce inactive metabolites. Metabolism can be blocked by replacing the susceptible acetoxy group with metabolically stable groups. Ø A methyl substituent at position 3 is good for oral absorption but bad for activity unless a hydrophilic group is present at the α-position of the acyl side chain. Ø Cephamycins are cephalosporins containing a methoxy group at position 7. Ø Oximinocephalosporins have resulted in several generations of cephalosporins with increased potency and a broader spectrum of activity, particularly against Gram-negative bacteria.
  • 110. Al-Zaytoonah University of Jordan Faculty of Pharmacy MedChem 3 Course #: 0201511 3 Credit Hours Ø Aminoglycosides
  • 111. Ø Aminoglycosides are irreversible inhibitors of protein synthesis. Ø They are active against aerobic gram negative bacilli and staphylococci. Ø The initial event is passive diffusion via channels across the outer membrane. Drug is then actively transported across the cell membrane into the cytoplasm by an oxygen- dependent process, which is coupled to a proton pump. Ø Low extracellular pH and anaerobic conditions inhibit transport by reducing the gradient. Transport may be enhanced by cell wall-active drugs, such as penicillins.
  • 112. Ø They bind irreversibly to a receptor protein on the 30S ribosomal subunit and blocks the formation of a complex that includes mRNA, formylmethionine, and tRNA. Protein synthesis is inhibited by aminoglycosides. (1) They interfere with the initiation complex of peptide formation. (2) They induce misreading of mRNA, which causes incorporation of incorrect amino acids into the peptide, resulting in a nonfunctional or toxic protein.
  • 113. Ø They are strongly basic compounds that exist as poly cations at physiological pH. Their inorganic acid salts are very soluble in water (as sulfates). Ø Solutions of the aminoglycoside salts are stable to autoclaving. Ø The high water solubility of the aminoglycosides contributes to their pharmacokinetic properties. They distribute well into most body fluids but not into the central nervous system, bone, fatty or connective tissues. Ø They tend to concentrate in the kidneys and are excreted by glomerular filtration. Metabolism of aminoglycosides in vivo apparently does not occur. O O OH NH 2 H2N O CH 2 OH H2N OH OH O OH CH 2 NH 2 HO HO Kanamycin C Ø Aminoglycosides structures consist of amino sugars linked glycosidically to 1,3-diaminoinositol.
  • 114. The antibacterial spectrum (e.g. kanamycin) was limited by resistance in many species of bacteria, this is due to the presence of R factors which direct the synthesis of a new family of enzymes that inactivate aminoglycoside by three separate mechanisms: acetylation, adenylation and phosphorylation.
  • 115. SAR (Ring I (A)) ØRing I (Ring A) is crucial for antibacterial activity. ØIt is the target for enzymatic inactivation and so any change in the substitution patterns can lead to significant changes in antibacterial activity. ØThe number and location of amino functions in ring I can affect SAR. Kanamycin B
  • 116. ØKanamycin B > Kanamycin A > kanamycin C , thus indicating the greater importance of the 6'-amino group over the the 2‘-amino group. ØAcylation of either the 6'- or 2'- amino groups lead to a severe decrease in potency. Ø6'- position C- or N- methylation can lead to retention, or even improvement of potency, 6'-N- methylation can have a beneficial effect by preventing inactivation via 6- acetyltransferase enzymes. O O OH NH 2 OH O NH 2 H2N OH OH O OH HO H2N HO H H S S R R R R R S S S R R R S S Kanamycin A O O OH NH 2 H2N O CH 2 OH H2N OH OH O OH CH 2 NH 2 HO HO Kanamycin C Kanamycin B 6’
  • 117. Ø Replacement of hydroxyl groups by hydrogen can lead to an improved potency and spectrum of action. Ø Conversion of Kanamycin B to its 3'- deoxy or 3', 4’ dideoxy derivative (Tobramycin or Dibekacin respectively) leads to a substantial improvement in activity against Pseudomonas aeurginosa and a small improvement against other species. O O OH NH 2 OH O NH 2 H2N OH OH O NH 2 H2N HO H H S S S R R R R S S S R R R S Tobramycin Kanamycin B
  • 118. Ø Unsaturation in ring I of Kanamycin B: by replacing the 3',4'- hydroxyl groups by a double bond diminished activity, Ø While introduction of a 4',5'- double bond gives a potent derivative . NHEt NHMe Me O O OH OH O H2N OH O NH 2 H2N H H S R R S R R R S R S R Netilmicin
  • 119. SAR (Ring II (B)) Ø The most important modification to the 2-deoxystreptamine ring has been acylation of the 1-amino with 2- hydroxyl-4- aminobutyric acid (HABA) as in Amikacin, which improves activity against resistant bacteria. Ø Methylation of 1,3-diamino groups gives Spectinamine ring. O O N H OH HO O H2N O H2N OH OH OH O OH NH 2 HO H2N HO H H S S R S R R R S S S S R R R S S Amikacin 2-deoxystreptamine ring improves activity against resistant bacteria.
  • 120. SAR (Ring III (C)) Ø When ring III is a pyranose ring, removal or methylation of the 2"- hydroxyl group has led to a considerable decrease in antibacterial activity, although activity is retained on replacement of the 2"- hydroxyl by an amino group, as in Seldomycin-5. Ø The 3"-group may be a primary or secondary amino group. Ø The 4"-hydroxyl may be axial or equatorial. Ø Several modifications at the 6"-position have led to a retention of antibacterial activity.
  • 121. Ø When ring III is a furanose ring, the 3"-hydroxyl may be substituted as in Neomycin and Paromomycin. Ø Possession of a fourth ring, as in Neomycin, generally leads to increased potency. O O O H2N NH 2 OH HO O NH 2 HO HO HO O OH O NH 2 OH NH 2 OH H H H R S R S R S R R S R S R S R R R S R S Paromomycin 3 Substituted OH With a 4th ring increases activity
  • 122. Me NHMe OHC O O O O OH OH OH OH N H HO OH HO NH NH 2 N H NH NH 2 H H R S R R S S S S R R S R R S R Streptomycin Streptidine ring
  • 124. Al-Zaytoonah University of Jordan Faculty of Pharmacy MedChem 3 Course #: 0201511 3 Credit Hours Rima Hajjo, MS, PhD r.hajjo@zuj.edu.jo Macrolide Antibiotics
  • 125. Macrolides Intramolecular ketal formation in Erythromycin. Responsible for basic properties of macrolides 1 6 9 2 The problem! Macrocyclic lactone Aglycone Glycon Ø Macrolides are a class of natural and semisynthetic antibiotics. Ø For bacterial and fungal infections. Ø Mechanism of action: inhibit protein synthesis. Ø Acid sensitive 12
  • 126. Mechanism of acid catalyzed intramolecular ketal formation with Erythromycin 1 6 9 2 Just remember the simple basics: OH on position 6 will do a nucleophilic attack on carbonyl carbon on position 9. Ketal is inactive! (that’s’ bad)!
  • 127. Methods for protecting erythromycin from acid catalyzed ketal formation 1. The hydroxyl groups are changed to methoxy groups as in clarithromycin which has improved acid-stability and oral absorption. 2. Increasing the member atoms of the macrolide (e.g. 15-membered ring of azithromycin). 3. Formation of salts with fatty acids
  • 128. SAR of Macrolides EM: Erythromycin CAM: Clarithromycin If R1 is phenyl: carbazate If R1 is alkyl: carbamate
  • 130. Erythromycin ØExample: isolated from Streptomyces erythreus. ØOne of the safest antibiotics in clinical use. ØThe structure consists of a 14-membered macrocyclic lactone ring with a sugar and an amino sugar attached. The sugar residues are important for activity. Ø Erythromycin binds to the 50S subunit of bacterial ribosomes. And, it inhibits translocation. Ø Erythromycin & Chloramphenicol bind to the same region of the ribosome, they shouldn’t be administered together as they will compete with each other and be less effective. Ø Erythromycin is unstable to stomach acids but can be taken orally in a tablet form (coated tablet). Ø The acid sensitivity is due to the presence of a ketone and 2 alcohol groups which are set up for the acid-catalyzed intramolecular formation of a ketal.
  • 131. Chemical Modifications to Increase the Stability of Macrolide Antibiotics Ø To prevent ketal formation, protection of hydroxyl groups was applied in clarithromycin. Ø The methoxy analogue is more stable to gastric juice and has improved oral absorption. Ø Another method of increasing acid stability is to increase the size of the macrocycle ring. Ø Azithromycin contains a 15- membered macrocycle where an N- methyl group is incorporated into the macrocycle (Erythromycin has a 14-memebered macrocyclic ring)
  • 132. The two hydroxyl groups that cause the intramolecular ketal formation in erythromycin have been masked, one as OCH3, and the other as part of the carbamate ring. The cladinose sugar in erythromycin has been replaced with a keto-group A carbamate ring has been fused to the macrocyclic ring. Telithromycin Telithromycin: A semi-synthetic derivative of erythromycin 3 3 6 12 9 v v Chemical Modifications to Increase the Stability of Macrolide Antibiotics
  • 133. Spectrum of Activity ØThe macrolides are bacteriostatic antibiotics with a broad spectrum of activity against many Gram positive aerobic bacteria (Clarithro > Erythro > Azithro), and Gram negatives aerobes (Azithro > Clarithro > Erythro). ØCurrently available macrolides are well tolerated, orally available. ØWidely used to treat mild-to-moderate infections. ØSeveral macrolidem antibiotics have been linked to liver injury.
  • 134. Water Solubility Ø The free bases of erythromycin and its analogs are moderately soluble in water Ø Water solubility can be improved by salt formation with some organic acids such as glucoheptonic and lactobionic acids to be used for parenteral administrations Ø Water solubility can be decreased if salts are prepared with fatty acids as stearate, estolate and laurylsulfate salts. Ø Erythromycin stearate is a very insoluble salt form of erythromycin. The water insolubility helps: 1) To increase stability toward acids 2) To increase oral absorption 3) To mask bitter taste
  • 135. Al-Zaytoonah University of Jordan Faculty of Pharmacy MedChem 3 Course #: 0201511 3 Credit Hours Rima Hajjo, MS, PhD r.hajjo@zuj.edu.jo Antibiotics that Impair Protein Synthesis Ø Lincosamides Ø Chloramphenicol
  • 136. Lincosamides - Introduction Ø The lincosamides contain an unusual 8-carbon sugar, a thiomethyl amino- octoside (O -thio-lincosamide), linked by an amide bond to an n -propyl substituted N -methylpyrrolidylcarboxylic acid (N -methyl-n -propyltrans- hygric acid). Ø Lincosamides are weakly basic and form clinically useful hydrochloric acid salts. Ø They are chemically distinct from the macrolide antibiotics but possess many pharmacologic similarities to them. Ø The lincosamides are bacteriostatic, they bind to 50S ribosomal subparticles at a site partly overlapping with the macrolide site and are mutually cross-resistant with macrolides and work through essentially the same molecular mechanism of action. Ø The lincosamides undergo extensive liver metabolism resulting primarily in N -demethylation. Ø The N -desmethyl analog retains biologic activity.
  • 137. Lincosamides SN2 Reaction and inversion of stereochemistry Methyl 6,8-dideoxy-6-(1-methyl- trans-4-propyl-L2- pyrolidinecarboxamido)-1-thio-D- erythro-α-D-galactooctopyranoside
  • 138. Lincomycin (Lincocin) ØLincomycin is a natural product isolated from fermentations of Streptomyces lincolnensis. ØIt is active against gram-positive organisms including some anaerobes. ØIt is generally reserved for penicillin-allergic patients due to the increased risk of pseudomembranous colitis. ØIt also serves as the starting material for the synthesis of clindamycin (by an SN-2 reaction that inverts the R stereochemistry of the C-7 hydroxyl to a C-7 S-chloride).
  • 139. Clindamycin (Cleocin) ØThe substitution of the chloride for the hydroxy group consequently makes clindamycin more bioactive and lipophilic than lincomycin, and thus, it is betterabsorbed following oral administration. ØIt is about 90% absorbed when taken orally. ØClindamycin has a clinical spectrum rather like the macrolides, although it distributes better into bones. ØClindamycin works well for gram-positive coccal infections, especially in patients allergic to β-lactams, and also has generally better activity against anaerobes.
  • 140. Clindamycin – cont. Ø The most severe of these (black box warning) is pseudomembranous colitis caused Clostridium difficile, an opportunistic anaerobe. Its overgrowth results from suppression of the normal flora whose presence otherwise preserves a healthier ecologic balance. The popularity of clindamycin in the clinic has decreased even though pseudomembranous colitis is comparatively rare and is also associated with several other broad-spectrum antibiotics. Ø A less common side effect is exudative erythema multiform (Stevens-Johnson syndrome). Clindamycin has excellent activity against Propionibacterium acnes when applied topically. Ø A very water-insoluble palmitate hydrochloride prodrug of clindamycin is also available (lacks bitter taste). Ø However, as with lincomycin, it is associated with GI complaints (nausea, vomiting, cramps, and drug-related diarrheas).
  • 141. Spectrum of Activity Lincosamideshave an unusual antimicrobial spectrum, being active against only Gram-positive and not Gram- negative aerobic bacteria but widely and potently active against anaerobic bacteria and some protozoa.
  • 142. Chloramphenicol Chloramphenicol is an antibiotic useful for the treatment of a number of bacterial infections: 1) Eye ointment to treat conjunctivitis 2) Orally or by injection into a vein, it is used to treat meningitis, plague, cholera, and typhoid fever.
  • 143. Al-Zaytoonah University of Jordan Faculty of Pharmacy MedChem 3 Course #: 0201511 3 Credit Hours Rima Hajjo, MS, PhD r.hajjo@zuj.edu.jo Antibacterial Agents that Impair Protein Synthesis Ø Tetracyclines and Glycylcyclines
  • 144. Introduction Ø Tetracyclines are antibiotcs isolated from Streptomyces aureofaciens (aureo meaning golden color). Ø They are broad spectrum, act on Gram-positive, Gram-negative, aerobic and anerobic bacteria. Ø most widely prescribed after penicillins. Ø Bacteriostatic antibiotics. Ø Inhibit protein synthesis by binding to the 30S subunit of ribosomes and preventing aminoacyl-tRNA from binding. Ø They inhibit protein synthesis in bacteria. Ø Selectivity is due to the ability of bacterial cells to concentrate these agents faster than human cells. Ø In the case of Gram-negative bacteria, tetracyclines cross the outer membrane by passive diffusion through the porins. Passage across the inner membrane is dependent on a pH gradient, which suggests that a proton- driven carrier is involved.
  • 146. Tetracyclins: General Structure This family of antibiotics is characterized by a highly functionalized, partially reduced naphthacene (four linearly fused six-membered rings) ring system from which both the family name and numbering system are derived.
  • 147. Schematic representation of the primary binding site for a tetracycline and the sugar phosphate groups of 16S rRNA, which also involves a magnesium ion and the critical functional groups on the “southern” and “eastern” face of the tetracycline. Mechanism of Action
  • 148. Chemical Instabilities I. Acid-catalyzed Instabilities of Tetracyclins II. Base-catalyzed Instabilities of Tetracyclins III. Chelation with metals IV. Phototoxicity
  • 149. I. Acid-catalyzed Instabilities of Tetracyclinns: Dehydration A tertiary and benzylic hydroxyl group at C6 is unstable. This degradation product is toxic to the kidneys and produces a Fanconi-like syndrome that, in extreme cases, has been fatal Tetracyclines that have no C-6-hydroxyl groups, such as minocycline and doxycycline, cannot undergo dehydration and thus are completely free of this toxicity. Secondary alcohol on C6 is more resistant to dehydration.
  • 150. II. Base-catalyzed instabilities of Tetracyclins Inactive lactone-derivative Active
  • 152. Metal Chelation ØChelation is an important feature of the chemical and clinical properties of the tetracyclines. The acidic functions of the tetracyclines are capable of forming salts through chelation with metal ions. ØThe salts of polyvalent metal ions, such as Fe2+, Ca2+, Mg2+, and Al3+, are all quite insoluble at neutral pHs, insolubility is not only inconvenient for the preparation of solutions, but also interferes with blood levels on oral administration. ØConsequently, the tetracyclines are incompatible with coadministered multivalent ion-rich antacids, and concomitant consumption of food rich in calcium (ions are contraindicated 1 hour before or 2 hours after the tetracyclines).
  • 153. Tetracyclin-Induced Teeth Discoloration ØBones and teeth are calcium-rich structures at nearly neutral pHs and so accumulate tetracyclines in proportion to the amount and duration of therapy when bones and teeth are being formed. Because the tetracyclines are yellow, this leads to a progressive and essentially permanent discoloration in which, in advanced cases, the teeth are even brown. ØThis is cosmetically unattractive but does not seem to be deleterious except in extreme cases where so much antibiotic is taken up that the structure of bone is mechanically weakened. To avoid this, tetracyclines are not normally given to children or pregnant women.
  • 154. The keto-enol tautomerism of ring A at C1 and C3 is a common feature to all biologically active tetracyclines, derivatives at C1 and C3 results blocking this system and loss of antibacterial activity SAR of Ring A
  • 155. Ø The amide is best left unsubstituted. Ø N-monoalkylation results in prodrug which can be hydrolyzed in vivo to parent compound. SAR of Ring A
  • 156. SAR of Ring A Ø The α-H at C-4a position of is necessary for useful antibacterial activity. Ø The α-C-4 dimethyl amino substituent supports the keto-enolic character of the A-ring. Ø Loss of activity occurs if dimethyl amino group is: -having reversed stereochemistry -being replaced with hydrazone (-N-N=C), oxime (-N-OH) or hydroxyl (-OH) The basic function is the C-4-a-dimethylamino moiety.
  • 157. SAR of Ring A Larger alkyl group àdisturb C1-C2- C3 tautomerism àreduce antibacterial activity e.g. Rolitetracyline is a prodrug which is more water soluble
  • 158. SAR of Ring B: C5 and C5a ØAll natural active tetracyclines have unsubstituted C5 (i.e. R4=H). ØAlkylation of the C-5 hydroxyl group (i.e. R4=CH3) results in loss of activity. ØSubstitution with C-5 α-hydroxyl group (i.e. R4=OH) give potent compound (e.g. oxytetracycline). ØCan be esterified to small alkyl esters to form semisynthetic tetracyclines which releases oxtetracycline in vivo (prodrug).
  • 159. SAR: ring C (position C6) ØThe mostly used ring to prepare semi-synthetic analogues. ØUsually, natural tetracyclins have α-methyl group and α-β-hydroxyl group at this position. ØThe C6 methyl group contributes little to the activity of tetracycline. ØThe C6 position is tolerant to a variety of substituents. ØDemeclocyclin is a naturally occurring C6 α-demethylated Chlortetracycline with an excellent activity. ØUnstable in acidic and basic media.
  • 160. SAR of Ring C: Modifications at C6 Ø6-Deoxytetracyclines possess important chemical and pharmacokinetic advantages 6-oxy tetracyclins. More stable under both acidic and basic media. Ø Unstable in strongly acidic conditions. Suffers prototropic rearrangement to the anhydrotetracycline in acid. Ø Stable in basic media: stable to -ketone cleavage followed by lactonization to the isotetracycline in base. ØReduction of the C6 hydroxyl group also dramatically changes the solubility properties of tetracyclines. This effect is reflected in significantly higher oil/water partition coefficients of the 6-deoxytetracyclines than of the tetracyclins. 6
  • 161. Make a secondary alcohol at position C6 (Eliminate CH3 at C6) Eliminate OH group at position C6 Summary: How to Increase the Stability of Tetracyclins? Tetracycline Minocycline
  • 162. SAR: Lipophilic Tetracyclins (6-deoxy cps.) ØThe greater lipid solubility of the 6-deoxy compounds (such as doxycycline and minocycline has important pharmacokinetic consequences (absorption, distribution and protein binding). ØPK properties of Doxycycline and minocycline: (1) Absorbed more completely following oral administration (2) Exhibit higher fractions of plasma protein binding (3) Have higher volumes of distribution and lower renal clearance rates than the corresponding 6-oxytetracyclins.
  • 163. SAR of rings C & D: Effect on Half lives (t1/2) Derivatives have been synthesized without 6-OH, these agents were more stable, lipophilic and long lasting than those with 6-OH group. Long lasting Longer t1/2
  • 164. SAR of Ring D and Structure-Toxicity Relationships ØRing D must be aromatic. ØC7-Cl causes phototoxicity. Ø Certain tetracyclines, most notably those with a C7-chlorine, absorb light in the visible region, leading to free radical generation and potentially causing severe erythema to sensitive patients on exposure to strong sunlight.
  • 165. SAR of ring D: C7 and C9
  • 166. SAR of ring D: C7 and C9
  • 167. SAR Rules: Activity is lost by: - Double bond between 5a and 11a - Aromatization of ring C Ring D must be aromatic
  • 169. Spectrum of Activity and Clinical Use ØAntimicrobial spectra of various tetracyclines are similar. ØThey have the broadest spectrum of activity, on both gram +, gram – and atypical bacteria. ØDue to resistance and toxicity, penicillins replaced them in many infections, especially the respiratory infections. ØTetracyclines are still used in rickettsia, Chlamydia, mycoplasma and acne infections. ØSome of them have antiparasitic properties such as the use of Doxycycline in the treatment and prophylaxis of malaria. ØThey have bacteriostatic action, not recommended in life threatening infections such as septicemia, endocarditis and meningitis.
  • 170. Mechanism of Uptake and Resistance to Tetracyclins
  • 171. Glycylcyclines ØThese tetracycline analogues are specifically designed to overcome two common mechanisms of tetracycline resistance: (1) resistance mediated by acquired efflux pumps and/or (2) ribosomal protection. Ø Glycylcyclines are a class of antibiotics derived from tetracycline. Ø Tigecycline is the only glycylcycline approved for antibiotic use. Ø Broad spectrum including MRSA. Tigecycline 9-tert -butylglycylamido derivative of minocycline. Glycine